Redundant prepuce, phimosis and paraphimosis

N14_PHIMOSIS

phimosis: A condition in which there is constriction in the tip of the foreskin resulting in inability to fully retract the foreskin over the glans penis. Causes include balanoposthitis, balanitis xerotica obliterans, and untreated diabetes.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule only males	226837
2. Check conditions None	226837
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — N47 Hospital discharge: ICD-9 — 605 Hospital discharge: ICD-8 — 605 Cause of death: ICD-10 — N47 Cause of death: ICD-9 — 605 Cause of death: ICD-8 — 605 2 out of 7 registries used, show all original rules.	9961
4. Check minimum number of events None	9961
5. Include endpoints None	9961
6. Filter based on genotype QC (FinnGen only)	9961

Control definitions (FinnGen only)

Control exclude: N14_MALEGEN

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: N40-N51
Name in latin: Praeputium redundans, phimosis sive paraphimosis

NAME	N14_PHIMOSIS
CONTROL_EXCLUDE	N14_MALEGEN
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX	1
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	N47
HD_ICD_9	605
HD_ICD_8	605
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	N47
COD_ICD_9	605
COD_ICD_8	605
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Redundant prepuce, phimosis and paraphimosis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	122230	-	122230
Only index persons	113219	-	113219
Unadjusted period prevalence (%)
Whole population	3.42	-	3.42
Only index persons	4.32	-	4.32
Median age at first event (years)
Whole population	-	-	15.09
Only index persons	-	-	15.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9961	-	9961
Unadjusted period prevalence (%)	4.39	-	4.39
Median age at first event (years)	29.55	-	29.55

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
8923: Matched controls
88991

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

7542

FHL

Circumcisio

692.0

323.0

991

N48.1

ICD-10 Finland

Balanoposthitis

12.3

323.0

790

695

KGH10

NOMESCO Finland

Operation for phimosis

1359.7

323.0

4220

KED22

NOMESCO Finland

Transurethral resection of prostate

28.5

323.0

451

166

N40

ICD-10 Finland

Hyperplasia of prostate

4.7

323.0

1839

4625

N47

ICD-10 Finland

Redundant prepuce, phimosis and paraphimosis

1205.4

323.0

5609

126

6050A

ICD-9 Finland

Redundant prepuce and phimosis[PHIMOSIS]

+∞

323.0

1044

WX240

NOMESCO Finland

Penis blockade

583.4

323.0

393

XKD00

NOMESCO Finland

Uroflowmetry

4.5

323.0

1607

4121

60500

ICD-8 Finland

Redundant prepuce and phimosis, Phimosis

+∞

323.0

2063

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

4.4

322.6

1294

3283

UKC02

NOMESCO Finland

Cystoscopy

3.9

300.8

1421

4171

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

5.0

206.9

718

1537

R33

ICD-10 Finland

Retention of urine

4.8

191.6

681

1492

60508

ICD-8 Finland

Redundant prepuce and phimosis, Alii definiti

+∞

157.6

151

G04CA02

ATC

tamsulosin; oral

2.1

149.6

2105

11432

215

Kela drug reimbursment

Diabetes, non-insulin-treated

2.0

139.2

2224

12657

103

Kela drug reimbursment

Diabetes, insulin-treated

1.9

134.7

2404

14239

N48.6

ICD-10 Finland

Induratio penis plastica

115.6

126.2

137

A10BA02

ATC

metformin; oral

1.9

122.4

2241

13311

L90.0

ICD-10 Finland

Lichen sclerosus et atrophicus

13.6

121.1

215

161

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

2.0

120.3

1868

10422

T90

ICPC

Diabetes non-insulin dependent

2.0

115.4

1847

10402

J01MA02

ATC

ciprofloxacin; systemic

1.8

112.3

2688

17383

KGH96

NOMESCO Finland

Other reconstructive operation on penis

150.3

112.3

119

XJH00

NOMESCO Finland

Transanal ultrasonography

4.1

108.0

453

1155

KGA10

NOMESCO Finland

Incision of prepuce

117.2

107.1

116

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

2.6

98.2

800

3278

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

3.1

97.7

581

1953

G04CA52

ATC

tamsulosin and dutasteride; systemic

2.7

94.8

702

2717

SPAT1262

SPAT

Handing over of treatment supplies

1.9

91.7

1455

8082

R31

ICD-10 Finland

Unspecified haematuria

2.5

91.6

771

3211

A10AE04

ATC

insulin glargine; parenteral

2.2

89.8

993

4741

N35.9

ICD-10 Finland

Urethral stricture, unspecified

8.8

89.7

199

231

KFD20

NOMESCO Finland

Excision of hydrocele of testis

95.8

86.0

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.6

83.4

658

2637

G04CA01

ATC

alfuzosin; oral

2.1

83.0

1064

5412

J01DB01

ATC

cefalexin; oral

1.6

82.1

6536

56205

J01EA01

ATC

trimethoprim; systemic

2.6

81.7

642

2569

TKD00

NOMESCO Finland

Dilatation of urethra

17.2

81.5

131

G04CB02

ATC

dutasteride; oral

3.2

80.0

446

1430

N02BE01

ATC

paracetamol; systemic, rectal

1.6

77.9

6305

53979

7541

FHL

Dorsal incision

762.8

77.3

N43.3

ICD-10 Finland

Hydrocele, unspecified

13.7

75.6

133

WX320

NOMESCO Finland

Spinalanesthesy

1.9

75.0

1272

7191

N45.9

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis without abscess

7.3

73.0

181

251

6050B

ICD-9 Finland

Redundant prepuce and phimosis[PARAPHIMOSIS]

+∞

71.9

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.9

71.4

1189

6664

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

70.9

475

1722

N46

ICD-10 Finland

Male infertility

21.2

70.3

105

N48.8

ICD-10 Finland

Other specified disorders of penis

20.0

70.3

107

G04BD12

ATC

mirabegron; oral

2.9

70.1

467

1687

A10BK03

ATC

empagliflozin; oral

2.4

69.9

640

2771

Y81

ICPC

Phimosis/redundant prepuce

36.1

66.6

A10BH01

ATC

sitagliptin; oral

2.2

65.4

734

3502

KED33

NOMESCO Finland

Transurethral incision of prostate

11.5

64.6

123

108

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.8

62.8

425

1551

N43.4

ICD-10 Finland

Spermatocele

9.3

61.6

131

142

6000A

ICD-9 Finland

Hyperplasia of prostate[HYPERPLASIA PROSTATAE]

+∞

61.4

KGH80

NOMESCO Finland

Plastic repair of skin of penis

160.6

60.9

KDH10

NOMESCO Finland

Meatoplasty of urethra

48.9

60.2

D07AC01

ATC

betamethasone; topical

1.5

60.1

2296

16288

KED52

NOMESCO Finland

Visual laser resection of prostate

84.2

59.9

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

57.7

1743

11646

60509

ICD-8 Finland

Redundant prepuce and phimosis, Unspecified

+∞

57.3

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.1

57.3

712

3545

N43.0

ICD-10 Finland

Encysted hydrocele

120.5

55.8

N48.0

ICD-10 Finland

Leukoplakia of penis

59.3

55.4

SPAT1167

SPAT

Insertion of urinary catheter

4.2

55.1

220

536

SPAT1263

SPAT

Sampling

1.5

55.0

2741

20534

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

2.5

54.9

450

1836

N30.0

ICD-10 Finland

Acute cystitis

3.0

53.1

330

1139

KGV10

NOMESCO Finland

Freeing of adhesions of prepuce

183.9

52.9

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

50.0

1503

9984

WX110

NOMESCO Finland

Local anesthesy

1.4

49.9

5284

45307

D07AD01

ATC

clobetasol; topical

1.8

49.3

935

5436

KDV10

NOMESCO Finland

Internal urethrotomy

10.3

48.4

J01MA12

ATC

levofloxacin; systemic

1.7

48.2

1185

7448

R35

ICD-10 Finland

Polyuria

2.5

47.8

402

1660

G04BD08

ATC

solifenacin; oral

3.0

47.4

285

962

KF8AE

NOMESCO Finland

Ultrasound examination of scrotum

3.6

47.3

223

629

D07AB02

ATC

hydrocortisone butyrate; topical

1.5

47.1

1731

12057

G47.3

ICD-10 Finland

Sleep apnoea

1.5

46.7

1821

12849

TKC22

NOMESCO Finland

Catheterisation instruction

5.4

46.4

144

270

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.9

46.4

709

3819

E0000UV

ATC

1.4

46.3

2492

18812

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

46.1

3591

29012

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.8

46.0

864

4999

A10BB12

ATC

glimepiride; oral

2.2

45.8

519

2478

J02AC01

ATC

fluconazole; systemic

1.6

45.5

1230

7925

A28

ICPC

Limited function/disability NOS

1.9

44.9

743

4118

J01CA08

ATC

pivmecillinam; oral

2.7

44.8

319

1201

XKD06

NOMESCO Finland

Physiologic investigation of micturition

4.3

43.7

167

391

KGB00

NOMESCO Finland

Biopsy of penis

23.9

43.5

E66.01

ICD-10 Finland

Obesity due to excess calories

2.2

42.5

465

2185

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

42.4

760

4329

160

Kela drug reimbursment

exenatide

3.6

41.7

197

557

R39.1

ICD-10 Finland

Other difficulties with micturition

3.2

41.4

230

736

N48.4

ICD-10 Finland

Impotence of organic origin

3.7

40.9

187

515

A98

ICPC

Health maint/preventive medicine

1.6

40.7

8007

75281

7543

FHL

Foreskin or frenulum plastic

+∞

40.6

J01DA01

ATC

[U] cefalexin; systemic

1.3

39.9

4426

37567

N44

ICD-10 Finland

Torsion of testis

38.6

39.6

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

39.5

1873

13705

TKC10

NOMESCO Finland

Percutaneous puncture of bladder

6.2

38.8

107

174

L28

ICPC

Limited function/disability (L)

1.8

38.5

737

4281

J01CA04

ATC

amoxicillin; systemic

1.4

38.5

6225

55902

C03CA01

ATC

furosemide; systemic

1.5

38.3

1516

10673

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

37.9

1435

10001

TKE00

NOMESCO Finland

Needle biopsy of prostate

2.9

37.6

239

836

C61

ICD-10 Finland

Malignant neoplasm of prostate

1.8

37.6

709

4100

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

37.4

1069

6965

E66.8

ICD-10 Finland

Other obesity

2.5

37.3

313

1290

A10AE05

ATC

insulin detemir; parenteral

2.0

37.2

494

2520

D07AC13

ATC

mometasone; topical

1.4

37.2

1841

13566

A10BJ06

ATC

semaglutide; parenteral

2.6

37.1

278

1076

A02BC02

ATC

pantoprazole; systemic

1.3

37.0

4071

34348

N41.1

ICD-10 Finland

Chronic prostatitis

3.5

36.8

175

499

SPAT1301

SPAT

No procedures

1.4

36.7

1868

13834

Y04

ICPC

Penis symptom/complaint other

4.5

36.4

132

295

U07

ICPC

Urine symptom/complaint other

2.8

36.1

237

849

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

35.8

775

4675

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

35.6

1923

14386

A10BJ02

ATC

liraglutide; parenteral

3.1

35.3

203

667

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

35.2

618

3486

J01FF01

ATC

clindamycin; systemic

1.4

35.1

1822

13527

A10BK01

ATC

dapagliflozin; oral

2.2

34.9

382

1795

U05

ICPC

Urination problems other

2.8

34.5

231

837

S18

ICPC

Laceration/cut

1.4

34.4

2683

21374

WX002

NOMESCO Finland

Sedation and analgesia

1.6

34.4

1130

7606

R06.0

ICD-10 Finland

Dyspnoea

1.5

34.4

1328

9275

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

34.2

534

2892

WX408

NOMESCO Finland

General anesthesy, balanced

1.4

34.1

1741

12875

U02

ICPC

Urinary frequency/urgency

2.3

34.1

324

1425

XCK10

NOMESCO Finland

Photography of fundus of eye

1.7

34.0

682

4017

M79.6

ICD-10 Finland

Pain in limb

1.4

33.9

1945

14696

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.8

33.8

613

3494

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.3

33.4

3085

25212

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

1.8

33.3

664

3902

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.7

33.3

720

4338

TKC20

NOMESCO Finland

Catheterisation of bladder

2.0

33.1

430

2174

SPAT1310

SPAT

Counselling related to known health issue

1.4

32.9

1893

14299

N30.9

ICD-10 Finland

Cystitis, unspecified

3.5

32.3

154

441

N02AX02

ATC

tramadol; systemic, rectal

1.3

32.1

2754

22223

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

31.9

1757

13155

KDV12

NOMESCO Finland

Urethroscopic internal urethrotomy

5.2

31.9

100

192

UJF32

NOMESCO Finland

Coloscopy

1.5

31.8

1384

9903

KFD30

NOMESCO Finland

Operation for spermatocele

43.3

31.7

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

31.5

2277

17866

N05CF01

ATC

zopiclone; oral

1.4

31.5

1774

13335

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.5

31.3

1088

7410

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

31.3

813

5155

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

31.0

830

5304

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.3

30.6

2771

22503

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.4

30.5

1569

11588

S29

ICPC

Skin symptom/complaint other

1.6

30.4

912

5994

H03AA01

ATC

levothyroxine sodium; systemic

1.7

30.1

730

4540

A10BX07

ATC

[U] liraglutide; parenteral

4.0

29.9

124

316

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

29.9

756

4753

R53

ICD-10 Finland

Malaise and fatigue

1.5

29.7

1050

7172

R01AD09

ATC

mometasone; nasal

1.3

29.6

2720

22112

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

2.8

29.4

192

687

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.1

29.3

362

1792

XKW99

NOMESCO Finland

Other physiological examination of urinary or male genital system

6.4

29.2

123

N35.8

ICD-10 Finland

Other urethral stricture

11.3

29.1

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

29.1

971

6542

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.6

29.1

813

5251

A46

ICD-10 Finland

Erysipelas

1.5

28.9

977

6603

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

28.6

835

5450

R03AC02

ATC

salbutamol; inhalant

1.3

28.3

3286

27561

60300

ICD-8 Finland

Hydrocele, Tunicae vaginalis testis

+∞

28.1

Y75

ICPC

Balanitis

8.8

28.0

R06AE07

ATC

cetirizine; oral

1.3

28.0

2634

21445

SPAT1254

SPAT

Administration of medicine

1.6

27.9

843

5544

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

27.9

237

985

SPAT1216

SPAT

Assessment of functional ability

1.6

27.6

703

4426

N41.0

ICD-10 Finland

Acute prostatitis

3.1

27.5

157

514

116

Kela drug reimbursment

Prostate cancer

1.9

27.4

414

2214

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

27.3

1108

7786

E66.00

ICD-10 Finland

Metabolic syndrome

1.9

27.0

387

2030

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

27.0

979

6719

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

26.7

822

5431

G04BD11

ATC

fesoterodine; oral

3.8

26.5

113

296

R42

ICD-10 Finland

Dizziness and giddiness

1.5

26.5

983

6777

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.9

26.5

161

552

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

26.4

993

6866

6030A

ICD-9 Finland

Hydrocele, Encysted hydrocele

+∞

26.0

7503

FHL

Hydrosel or funicular surgery

15.6

25.8

U08

ICPC

Urinary retention

4.0

25.7

105

265

N06AX11

ATC

mirtazapine; oral

1.4

25.7

1819

14145

7544

FHL

Other measure in this category

33.0

25.5

KGW96

NOMESCO Finland

Other operation on penis

44.3

25.4

L17

ICPC

Foot/toe symptom/complaint

1.4

25.2

1279

9388

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

2.3

25.0

242

1077

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

24.8

3528

30216

SPAT1229

SPAT

Assessment of need for aid

1.9

24.7

350

1829

S97

ICPC

Chronic ulcer skin

2.0

24.6

337

1741

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

24.6

7085

66267

KED76

NOMESCO Finland

TUVP

32.0

24.5

U29

ICPC

Urinary symptom/complaint other

3.4

24.5

122

364

A10BG03

ATC

pioglitazone; oral

2.6

24.5

189

747

N32.0

ICD-10 Finland

Bladder-neck obstruction

6.5

24.4

A10AE06

ATC

insulin degludec; parenteral

2.1

24.3

281

1355

R01AD08

ATC

fluticasone; nasal

1.4

24.2

1670

12920

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

1.8

24.1

443

2533

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

24.1

1677

12985

J01AA02

ATC

doxycycline; systemic

1.3

24.0

5192

46704

T89

ICPC

Diabetes insulin dependent

1.9

24.0

380

2066

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

23.9

2510

20647

N03AX16

ATC

pregabalin; oral

1.4

23.9

1217

8932

R60.0

ICD-10 Finland

Localized oedema

1.7

23.8

505

3019

162

Kela drug reimbursment

liraglutide

3.7

23.7

106

290

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

23.6

825

5608

L02AE02

ATC

leuprorelin; implant, parenteral

2.0

23.5

292

1450

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.7

23.5

466

2731

C08CA01

ATC

amlodipine; oral

1.3

23.4

2031

16253

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

23.4

1070

7689

205

Kela drug reimbursment

Chronic hypertension

1.4

23.3

1570

12084

60730

ICD-8 Finland

Other disease of male genital organs, Balanitis

+∞

22.9

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.3

22.3

215

956

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.9

22.3

323

1705

H81

ICPC

Excessive ear wax

1.5

22.2

919

6471

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

22.2

4602

41010

N48.5

ICD-10 Finland

Ulcer of penis

10.0

22.2

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

22.1

693

4594

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

22.1

1971

15818

7451

FHL

Transurethral adenoma removal

23.8

22.1

A10BD07

ATC

metformin and sitagliptin; systemic

1.9

22.0

310

1617

N06AX21

ATC

duloxetine; oral

1.7

21.9

490

2976

N06AB04

ATC

citalopram; systemic

1.4

21.9

1081

7882

N02AJ06

ATC

codeine and paracetamol; systemic

1.3

21.9

2467

20434

H02AB06

ATC

prednisolone; systemic

1.3

21.9

2813

23690

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.1

21.7

237

1118

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

21.6

668

4410

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

21.3

715

4813

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

1.8

21.3

365

2042

SPAT1325

SPAT

Vaccination

1.3

21.3

1779

14129

M01AB05

ATC

diclofenac; systemic, rectal

1.2

21.2

4588

40982

J01MA01

ATC

ofloxacin; systemic

1.7

21.2

411

2391

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

21.1

1151

8540

177

Kela drug reimbursment

Insulin glargine 300 U / ml

2.3

21.1

190

819

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.0

21.0

281

1438

A10BX09

ATC

[U] dapagliflozin; oral

3.7

20.9

250

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

4.3

20.8

183

WX290

NOMESCO Finland

Other blockade of nerve

1.2

20.6

3305

28511

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

20.6

875

6187

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.5

20.6

683

4586

N48.2

ICD-10 Finland

Other inflammatory disorders of penis

14.8

20.6

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

20.4

333

1833

A10BH05

ATC

linagliptin; oral

2.0

20.4

268

1362

N05BA04

ATC

oxazepam; oral

1.4

20.4

1237

9341

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

20.3

5056

45764

L02BB03

ATC

bicalutamide; oral

2.3

20.2

195

868

B01AB05

ATC

enoxaparin; parenteral

1.3

20.1

1484

11560

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.2

20.0

215

1008

A10AD05

ATC

insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.8

20.0

129

463

A04

ICPC

Weakness/tiredness general

1.6

19.9

573

3717

R06AE09

ATC

levocetirizine; oral

1.5

19.7

796

5578

N02AA05

ATC

oxycodone; systemic

1.5

19.6

752

5205

N39.3

ICD-10 Finland

Stress incontinence

4.9

19.6

131

XKC03

NOMESCO Finland

Water cystometry

3.5

19.5

270

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

19.5

917

6617

SPAT1053

SPAT

Memory test

1.5

19.5

606

4006

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

19.3

1187

8973

R07.4

ICD-10 Finland

Chest pain, unspecified

1.3

19.2

1490

11684

WZC30

NOMESCO Finland

Teaching

1.5

19.1

750

5219

M54.5

ICD-10 Finland

Low back pain

1.3

19.1

1850

14973

N06AB10

ATC

escitalopram; oral

1.4

19.1

1120

8406

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

19.0

1766

14205

G04BD04

ATC

oxybutynin; oral, transdermal

2.3

19.0

177

776

N17

ICPC

Vertigo/dizziness

1.7

19.0

425

2579

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.3

19.0

2685

22770

A02BC05

ATC

esomeprazole; systemic

1.3

19.0

2167

17909

SPAT1312

SPAT

General health counselling

1.3

19.0

1813

14641

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

19.0

1469

11517

K02.1

ICD-10 Finland

Caries of dentine

1.2

18.9

4217

37587

SPAT1260

SPAT

Consultation of another employee

1.4

18.9

896

6471

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

18.9

1753

14102

M25.5

ICD-10 Finland

Pain in joint

1.3

18.8

1440

11263

N48.9

ICD-10 Finland

Disorder of penis, unspecified

7.3

18.8

J01MA06

ATC

norfloxacin; oral

1.7

18.8

394

2346

U01

ICPC

Dysuria/painful urination

2.5

18.7

144

574

TPH04

NOMESCO Finland

Cathetrisation of vein

1.4

18.6

1232

9421

G04BD07

ATC

tolterodine; oral

2.4

18.6

156

648

N05AH04

ATC

quetiapine; oral

1.4

18.6

1088

8157

WX702

NOMESCO Finland

Supraglottic ventilation device

1.9

18.5

290

1576

N06AB06

ATC

sertraline; oral

1.5

18.4

581

3853

WX400

NOMESCO Finland

Inhalation anesthesy

2.0

18.4

229

1143

P20

ICPC

Memory disturbance

1.6

18.3

444

2755

U04

ICPC

Incontinence urine

2.6

18.2

137

538

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

18.2

469

2961

SPAT1252

SPAT

Overall medication plan or its review

1.8

18.2

341

1967

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

18.0

3661

32259

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

18.0

393

2368

A10BX04

ATC

[U] exenatide; parenteral

3.5

18.0

246

R11

ICD-10 Finland

Nausea and vomiting

1.7

17.9

365

2158

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

17.9

1653

13272

EBA00

NOMESCO Finland

Extraction of tooth

1.3

17.9

2337

19609

C10AA01

ATC

simvastatin; oral

1.3

17.8

2412

20317

60798

ICD-8 Finland

Other disease of male genital organs, Alii definiti

+∞

17.7

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

2.8

17.7

114

410

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

17.6

512

3334

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

17.6

985

7329

J01FA10

ATC

azithromycin; systemic

1.2

17.5

3804

33712

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

17.5

256

1359

A02BC03

ATC

lansoprazole; oral

1.3

17.4

1461

11569

AA1AD

NOMESCO Finland

CT of head and brain

1.3

17.4

1319

10297

A10BJ01

ATC

exenatide; parenteral

3.8

17.3

197

A02BC01

ATC

omeprazole; systemic

1.3

17.3

1357

10646

D01BA02

ATC

terbinafine; oral; topical

1.3

17.3

1707

13827

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

17.2

3755

33269

E10.3

ICD-10 Finland

Type 1 diabetes mellitus, With ophthalmic complications

1.9

17.2

271

1475

B03BA03

ATC

hydroxocobalamin; parenteral

1.8

17.2

277

1520

T82

ICPC

Obesity

2.1

17.0

183

859

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

17.0

356

2125

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

16.9

664

4622

A10AB01

ATC

insulin (human); parenteral (insulins and analog. for injection, fast-acting)

1.8

16.9

320

1851

C07AB07

ATC

bisoprolol; oral

1.2

16.8

2634

22525

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

2.4

16.8

139

576

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

3.1

16.8

303

D01AC02

ATC

miconazole; topical

1.6

16.8

494

3221

P01AB01

ATC

metronidazole; oral, rectal

1.3

16.8

1785

14585

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

1.8

16.7

282

1573

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

16.7

695

4891

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.8

16.7

268

1469

KCW02

NOMESCO Finland

Lavation of bladder for coagulated blood

4.6

16.6

124

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

16.6

2147

17965

R02

ICPC

Shortness of breath/dyspnoea

1.5

16.5

557

3749

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

16.5

2241

18855

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

16.5

1035

7841

C60.1

ICD-10 Finland

Malignant neoplasm: Glans penis

16.2

16.5

Z01.2

ICD-10 Finland

Dental examination

1.2

16.4

2510

21402

E000006

ATC

1.8

16.3

299

1713

U06

ICPC

Haematuria

2.6

16.2

115

439

A06AD11

ATC

lactulose; oral

1.5

16.1

662

4650

N06AX16

ATC

venlafaxine; oral

1.4

16.0

707

5032

N45.0

ICD-10 Finland

Orchitis, epididymitis and epididymo-orchitis with abscess

16.7

16.0

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

2.5

16.0

129

526

KCD02

NOMESCO Finland

Transurethral resection of bladder

2.3

15.9

145

632

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

15.9

837

6155

Z00.0

ICD-10 Finland

General medical examination

1.3

15.9

1053

8046

U13

ICPC

Bladder symptom/complaint other

3.1

15.9

288

L03

ICPC

Low back symptom/complaint

1.3

15.8

1137

8798

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

1.6

15.7

462

3016

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

15.6

1647

13426

C05AA08

ATC

fluocortolone; rectal, topical

1.4

15.6

707

5056

60301

ICD-8 Finland

Hydrocele, Funiculi testis

+∞

15.6

L13

ICPC

Hip symptom/complaint

1.5

15.6

521

3501

E000001

ATC

1.3

15.6

1151

8936

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

15.5

751

5440

D07CC01

ATC

betamethasone and antibiotics; topical

1.4

15.5

706

5060

Y29

ICPC

Genital symptom/complaint male other

2.9

15.3

334

SPAT1097

SPAT

Recording of ECG

1.4

15.3

711

5110

N05BA01

ATC

diazepam; systemic, rectal

1.4

15.3

715

5143

N03AX12

ATC

gabapentin; oral

1.4

15.3

728

5258

XKD03

NOMESCO Finland

Urethral pressure profilometry

4.2

15.3

140

A10AD01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)

2.2

15.2

158

730

D07AB08

ATC

desonide; topical

1.5

15.2

557

3820

M03BX02

ATC

tizanidine; oral

1.2

15.1

4018

36125

J01FA06

ATC

roxithromycin; oral

1.2

15.0

2260

19195

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

2.0

14.9

180

890

E000002

ATC

1.4

14.9

632

4466

H3603, E103

ICD-10 Finland

2.6

14.8

109

425

H25.1

ICD-10 Finland

Senile nuclear cataract

1.4

14.8

902

6795

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.1

14.8

264

R06.5

ICD-10 Finland

Mouth breathing

1.4

14.7

634

4495

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

14.7

772

5673

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.8

14.7

249

1391

H13

ICPC

Plugged feeling ear

1.4

14.7

932

7070

A10AB04

ATC

insulin lispro; parenteral (insulins and analog. for injection, fast-acting)

1.8

14.7

269

1541

N41.9

ICD-10 Finland

Inflammatory disease of prostate, unspecified

2.8

14.6

344

H36.00

ICD-10 Finland

Diabetic background retinopathy

2.4

14.6

120

495

D07BC01

ATC

betamethasone and antiseptics; topical

1.4

14.6

690

4976

6088X

ICD-9 Finland

Other disorders of male genital organs, Other specified disorders of male genital organs

+∞

14.6

Z43.5

ICD-10 Finland

Attention to cystostomy

5.9

14.6

D07AA02

ATC

hydrocortisone; topical

1.4

14.4

800

5933

ZXA05

NOMESCO Finland

Left side

1.3

14.4

1343

10765

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.5

14.4

580

4054

TKF60

NOMESCO Finland

Puncture of scrotum

36.0

14.4

KGH20

NOMESCO Finland

Correction of induration or curvature of penis

36.0

14.4

N99.1

ICD-10 Finland

Postprocedural urethral stricture

6.5

14.2

SPAT1211

SPAT

Application of soft bandage

1.5

14.2

442

2923

N42.9

ICD-10 Finland

Disorder of prostate, unspecified

3.6

14.2

180

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

14.2

5273

48748

E66.9

ICD-10 Finland

Obesity, unspecified

2.0

14.1

170

841

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.7

14.1

299

1791

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

2.1

14.1

155

738

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.3

14.0

1104

8645

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

14.0

2518

21761

A02BA02

ATC

ranitidine; systemic

1.3

14.0

887

6725

UKD02

NOMESCO Finland

Urethroscopy

5.6

13.9

A10BG02

ATC

rosiglitazone; oral

2.7

13.9

338

E10.2

ICD-10 Finland

Type 1 diabetes mellitus, With renal complications

2.8

13.9

332

R06AX27

ATC

desloratadine; oral

1.3

13.8

1440

11704

M01AX05

ATC

glucosamine; oral

1.4

13.8

638

4583

A10BH02

ATC

vildagliptin; oral

2.4

13.7

116

490

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

13.6

284

1695

KGV00

NOMESCO Finland

Reduction of prepuce in paraphimosis

+∞

13.5

C09CA01

ATC

losartan; oral

1.3

13.5

1238

9894

Z71.8

ICD-10 Finland

Other specified counselling

1.3

13.5

1271

10198

M48.0

ICD-10 Finland

Spinal stenosis

1.5

13.5

501

3449

R05FB02

ATC

cough suppressants and expectorants

1.2

13.5

1932

16294

R03AC03

ATC

terbutaline; inhalant

1.4

13.5

698

5118

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.5

13.4

442

2962

H3603, E113

ICD-10 Finland

3.0

13.4

258

R03BA05

ATC

fluticasone; inhalant

1.3

13.4

945

7282

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.5

13.4

514

3562

D29.0

ICD-10 Finland

Benign neoplasm: Penis

18.2

13.3

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

13.3

195

1041

H36.01

ICD-10 Finland

Diabetic maculopathy

2.5

13.3

106

434

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.5

13.2

448

3021

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

13.2

325

2032

N05CF02

ATC

zolpidem; oral

1.3

13.2

862

6567

NK6AN

NOMESCO Finland

Total body bone isotope imaging

2.3

13.2

121

533

SPAT1153

SPAT

Removal of sutures

1.2

13.2

1688

14056

KGH05

NOMESCO Finland

Suture of skin of penis

39.9

13.1

L15

ICPC

Knee symptom/complaint

1.3

13.0

909

6993

A10AA02

ATC

1.7

13.0

263

1556

R51.80

ICD-10 Finland

Headache

1.4

13.0

665

4864

A10BB01

ATC

glibenclamide; oral

1.8

13.0

225

1269

M01AH05

ATC

etoricoxib; oral

1.2

13.0

3737

33671

P76

ICPC

Depressive disorder

1.6

12.9

306

1893

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.3

12.8

116

507

H02

ICPC

Hearing complaint

1.5

12.8

491

3402

J02AC02

ATC

itraconazole; systemic

1.4

12.8

780

5877

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

12.8

705

5226

G04BD09

ATC

trospium; oral

3.3

12.7

197

N05AX08

ATC

risperidone; systemic

1.5

12.7

497

3453

C10AA05

ATC

atorvastatin; oral

1.2

12.7

2221

19103

L16

ICPC

Ankle symptom/complaint

1.5

12.6

467

3209

R03DC03

ATC

montelukast; oral

1.4

12.6

726

5416

WZA90

NOMESCO Finland

Other doctors statement

1.3

12.6

1378

11261

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.5

12.6

399

2656

N43.2

ICD-10 Finland

Other hydrocele

12.2

12.6

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

3.0

12.5

242

L29

ICPC

Musculoskeletal sympt/complt other

1.6

12.5

308

1923

R01AD12

ATC

fluticasone furoate; nasal

1.2

12.5

1583

13154

N49.2

ICD-10 Finland

Inflammatory disorders of scrotum

7.0

12.5

KGV30

NOMESCO Finland

Implantation of prosthesis into penis

+∞

12.5

C60.0

ICD-10 Finland

Malignant neoplasm: Prepuce

17.3

12.5

D01AE15

ATC

terbinafine; topical

1.5

12.5

436

2962

CKC12

NOMESCO Finland

Photocoagulation of retina

1.7

12.4

259

1544

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

12.4

3967

36016

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

12.3

458

3153

M01AE02

ATC

naproxen; oral, rectal

1.2

12.3

3507

31517

SPAT1172

SPAT

Guidance concerning hydration

2.5

12.3

359

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.2

12.3

2780

24482

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

2.1

12.3

139

670

A01AB09

ATC

miconazole; local oral

1.6

12.2

321

2040

SPAT1245

SPAT

Provision of support and information to patient’s family members

1.9

12.1

181

970

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

1.8

12.1

212

1203

KMAK

NOMESCO Finland

1.2

12.1

3521

31685

R05

ICPC

Cough

1.3

12.1

1013

7997

R30.0

ICD-10 Finland

Dysuria

2.0

12.1

149

746

N50.8

ICD-10 Finland

Other specified disorders of male genital organs

4.2

12.0

104

KF8KT

NOMESCO Finland

Sclerotherapy of scrotum

26.6

12.0

N35.1

ICD-10 Finland

Postinfective urethral stricture, not elsewhere classified

21.2

12.0

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.3

12.0

1060

8431

1530

FHL

Urethrocystoscopy

2.6

11.9

322

S22

ICPC

Nail symptom/complaint

1.6

11.9

276

1697

N06AA09

ATC

amitriptyline; systemic

1.5

11.9

352

2306

B02AA02

ATC

tranexamic acid; systemic

1.8

11.9

217

1247

C09AA02

ATC

enalapril; systemic

1.3

11.9

1053

8374

358

Kela drug reimbursment

liraglutide

4.0

11.9

115

C09BA02

ATC

enalapril and diuretics; systemic

1.5

11.8

430

2945

A10BJ05

ATC

dulaglutide; parenteral

3.1

11.8

203

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.4

11.8

671

4998

ZXA00

NOMESCO Finland

Right side

1.2

11.8

1417

11696

P03

ICPC

Feeling depressed

1.5

11.8

432

2965

H04AA01

ATC

glucagon; nasal, parenteral

1.7

11.7

230

1351

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

11.7

537

3851

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

11.7

365

2419

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.7

11.7

245

1464

SPAT1168

SPAT

Catheterisation training

5.8

11.7

A10BD03

ATC

metformin and rosiglitazone; systemic

2.4

11.7

401

N05AA02

ATC

levomepromazine; systemic

1.6

11.7

293

1843

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

2.4

11.6

402

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.6

11.6

302

1915

H26.4

ICD-10 Finland

After-cataract

1.6

11.6

278

1727

SPAT1251

SPAT

Organisation of medication

1.9

11.5

162

851

B81

ICPC

Anaemia vit B12/folate deficiency

1.9

11.5

164

865

R32

ICD-10 Finland

Unspecified urinary incontinence

2.8

11.5

256

R06AX13

ATC

loratadine; oral

1.3

11.5

756

5759

ZXA10

NOMESCO Finland

Bilateral

1.3

11.5

854

6625

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.5

11.5

336

2193

L08

ICPC

Shoulder symptom/complaint

1.3

11.5

907

7104

6071X

ICD-9 Finland

Disorders of penis, Balanoposthitis[BALANITIS NONVENEREA ALIA]

+∞

11.4

60770

ICD-8 Finland

Other disease of male genital organs, Torsion of testis

+∞

11.4

KWD00

NOMESCO Finland

Reoperation for superficial haemorrhage in urological surgery

9.2

11.4

R03BA02

ATC

budesonide; inhalant

1.3

11.4

871

6784

Y77

ICPC

Malignant neoplasm prostate

1.8

11.4

177

966

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

2.1

11.4

119

558

A10AA01

ATC

1.7

11.3

224

1317

E10.8

ICD-10 Finland

Type 1 diabetes mellitus, With unspecified complications

2.3

11.3

105

467

A03FA02

ATC

cisapride; oral, rectal

1.6

11.2

285

1795

D07XC01

ATC

betamethasone, combinations; topical

1.3

11.2

702

5307

SPAT1234

SPAT

Support of social functional capacity

1.7

11.2

225

1333

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

11.2

2560

22526

KCE02

NOMESCO Finland

Transluminal endoscopic extraction of calculus from bladder

4.5

11.2

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

2.1

11.2

124

595

Y06

ICPC

Prostate symptom/complaint

1.9

11.2

163

870

R50.9

ICD-10 Finland

Fever, unspecified

1.3

11.2

823

6379

R06AX22

ATC

ebastine; oral

1.3

11.1

780

5999

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

11.1

447

3129

A10BX02

ATC

repaglinide; oral

2.7

11.0

283

SPAT1100

SPAT

Long-term monitoring of blood pressure

1.6

11.0

270

1687

KFA00

NOMESCO Finland

Exploration of testis

8.0

11.0

N12

ICD-10 Finland

Tubulo-interstitial nephritis, not specified as acute or chronic

2.9

11.0

225

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

11.0

1085

8745

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

11.0

933

7372

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

11.0

139

705

K07

ICPC

Swollen ankles/oedema

1.9

10.9

157

837

2500B

ICD-9 Finland

Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]

1.8

10.8

187

1056

A69

ICPC

General and Unspecified, Other reason for encounter NEC

2.0

10.8

129

640

CKC10

NOMESCO Finland

Local photocoagulation of retina

2.2

10.8

106

482

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.3

10.7

900

7102

XG466

NOMESCO Finland

Sleep oxymetry

1.7

10.7

213

1256

E11.1

ICD-10 Finland

Type 2 diabetes mellitus, with ketoacidosis

3.3

10.7

163

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

2.9

10.7

218

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

1.5

10.7

324

2134

A29

ICPC

General symptom/complaint other

1.4

10.6

504

3638

L60.0

ICD-10 Finland

Ingrowing nail

1.7

10.6

226

1358

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.4

10.6

514

3726

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

10.6

1417

11830

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

10.5

357

2413

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

10.5

3115

27976

S21

ICPC

Skin texture symptom/complaint

1.4

10.5

567

4191

E66

ICD-10 Finland

Obesity

1.7

10.4

207

1220

6038X

ICD-9 Finland

Hydrocele, Other specified types of hydrocele[HYDROCELE ALIA DEFINITA]

+∞

10.4

KCV12

NOMESCO Finland

Urinary bladder endoscopic botulin therapy

5.0

10.4

C03AA03

ATC

hydrochlorothiazide; oral

1.5

10.4

361

2452

D05AX52

ATC

calcipotriol, combinations; topical

1.5

10.4

358

2430

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

10.4

1608

13626

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

10.3

2475

21839

N30

ICD-10 Finland

Cystitis

2.3

10.3

410

H25.8

ICD-10 Finland

Other senile cataract

1.5

10.3

352

2385

F03

ICD-10 Finland

Unspecified dementia

1.9

10.2

147

782

NHQ40

NOMESCO Finland

Amputation of toe

2.1

10.2

105

490

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

10.2

614

4618

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.2

10.2

1408

11792

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.6

10.2

248

1551

X59

ICD-10 Finland

Exposure to unspecified factor

1.2

10.1

1260

10434

U70

ICPC

Pyelonephritis/pyelitis

3.4

10.0

139

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.4

10.0

494

3593

P01

ICPC

Feeling anxious/nervous/tense

1.4

10.0

461

3308

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

10.0

196

1152

C09AA05

ATC

ramipril; oral

1.2

10.0

1377

11521

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

10.0

353

2407

SPAT1240

SPAT

Therapeutic discussion

1.4

9.9

529

3899

H43.1

ICD-10 Finland

Vitreous haemorrhage

2.0

9.9

128

654

J01FA09

ATC

clarithromycin; systemic

1.2

9.9

1729

14817

S01GX01

ATC

cromoglicic acid; ophthalmic

1.3

9.9

916

7321

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

9.9

207

1245

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.2

9.8

419

TQW80

NOMESCO Finland

Local dermatologic skincare

1.9

9.8

138

728

A10BD15

ATC

metformin and dapagliflozin; systemic

2.7

9.8

237

ECB00

NOMESCO Finland

Suture of gingiva

1.7

9.8

208

1251

R05

ICD-10 Finland

Cough

1.3

9.8

849

6726

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

2.5

9.8

304

E87.5

ICD-10 Finland

Hyperkalaemia

2.3

9.8

380

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.7

9.8

192

1129

8070/3-C60.1

ICD-O-3

Squamous cell carcinoma, NOS, of glans penis

25.9

9.8

R06.2

ICD-10 Finland

Wheezing

1.6

9.7

222

1363

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.2

9.7

1175

9691

A10AB06

ATC

insulin glulisine; parenteral

2.4

9.7

337

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.2

9.7

1146

9432

C08CA13

ATC

lercanidipine; oral

1.4

9.7

563

4211

C01DA14

ATC

isosorbide mononitrate; oral

1.3

9.7

723

5615

UDC00

NOMESCO Finland

Ear microscopy

1.5

9.7

375

2609

SPAT1255

SPAT

Intravenous administration of medicine

1.5

9.6

333

2262

M70.6

ICD-10 Finland

Trochanteric bursitis

1.6

9.6

215

1315

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.5

9.6

376

2616

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

9.6

368

2554

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.2

9.5

1249

10393

D11

ICPC

Diarrhoea

1.4

9.5

560

4195

C10AA07

ATC

rosuvastatin; oral

1.2

9.5

1242

10338

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

9.5

457

3311

I50

ICD-10 Finland

Heart failure

2.0

9.5

120

609

104

Kela drug reimbursment

Thyroid insufficiency

1.8

9.5

153

851

-1

NOMESCO Finland

1.2

9.4

2171

19061

G44.2

ICD-10 Finland

Tension-type headache

1.4

9.4

452

3273

TPH07

NOMESCO Finland

Cathetrisation of artery

1.4

9.4

536

3997

SPAT1285

SPAT

Provision of consultation response

1.6

9.4

235

1483

6081A

ICD-9 Finland

Other disorders of male genital organs, Spermatocele

+∞

9.4

60760

ICD-8 Finland

Other disease of male genital organs, Spermatocele

+∞

9.4

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.2

9.4

1657

14207

R96

ICPC

Asthma

1.5

9.4

310

2085

TKW99

NOMESCO Finland

Other minor surgical procedure in urology

2.8

9.3

213

SPAT1070

SPAT

Doppler ultrasound examination of blood flow in arteries of lower extremity

2.2

9.3

384

C09DA01

ATC

losartan and diuretics; oral

1.4

9.3

485

3563

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.0

9.2

117

597

H36.09*E11.3

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic retinopathy

2.9

9.2

180

JN3AD

NOMESCO Finland

Abdominal CT examination

1.4

9.2

386

2725

A06AC51

ATC

ispaghula, combinations; systemic

1.7

9.1

175

1025

D07AB01

ATC

clobetasone; topical

1.8

9.1

138

750

CKC15

NOMESCO Finland

Panretinal photocoagulation

2.6

9.1

236

M01AX17

ATC

nimesulide; oral

1.2

9.1

1088

8964

S76

ICPC

Skin infection other

1.6

9.1

255

1653

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.7

9.1

185

1103

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

9.0

220

1375

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

1.8

9.0

136

739

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.2

9.0

1263

10583

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.4

9.0

509

3789

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.4

9.0

369

2596

KEB00

NOMESCO Finland

Biopsy of prostate

2.8

9.0

207

C60.9

ICD-10 Finland

Malignant neoplasm: Penis, unspecified

9.0

SPAT1104

SPAT

Monitoring of emergency patient

1.5

9.0

310

2108

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.2

9.0

2158

19005

N06AA12

ATC

doxepin; systemic

1.6

9.0

216

1348

N21.0

ICD-10 Finland

Calculus in bladder

3.1

9.0

147

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

1.7

8.9

161

925

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

1.8

8.9

148

830

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

2.7

8.9

209

R74

ICPC

Upper respiratory infection acute

1.2

8.9

1526

13039

S20

ICPC

Corn/callosity

2.1

8.8

100

488

HMAK

NOMESCO Finland

1.3

8.8

625

4815

R52.9

ICD-10 Finland

Pain, unspecified

1.4

8.8

351

2457

XF402

NOMESCO Finland

ECG with work load test

1.3

8.8

549

4155

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

8.8

309

2108

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.4

8.7

396

2837

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

8.7

253

1656

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.4

8.7

404

2906

J45

ICD-10 Finland

Asthma

1.4

8.7

404

2908

C09CA06

ATC

candesartan; oral

1.2

8.7

1012

8315

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

2.1

8.6

417

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

0.2

8.6

412

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.3

8.6

632

4894

N08.39

ICD-10 Finland

Glomerular disorders in diabetes mellitus microalbuminuria

2.9

8.6

179

D40.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other male genital organs

6.6

8.6

E10

ICD-10 Finland

Type 1 diabetes mellitus

1.7

8.6

160

931

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.4

8.6

372

2643

J05AB01

ATC

aciclovir; systemic

1.3

8.6

859

6927

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

8.6

103

516

SPAT1043

SPAT

Audiometry

1.4

8.6

417

3027

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.6

8.6

207

1294

R03BA01

ATC

beclometasone; inhalant

1.3

8.6

627

4855

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.4

8.6

398

2868

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

8.6

549

4172

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.6

8.5

200

1239

59802

ICD-8 Finland

Stricture of urethra, Meatus externi viri

16.2

8.5

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.5

8.5

323

2238

D12

ICPC

Constipation

1.9

8.5

119

630

G04BX08

ATC

4.4

8.5

SPAT1139

SPAT

Nutrition survey

1.8

8.5

131

719

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

2.2

8.5

393

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

1.8

8.5

142

798

U28

ICPC

Limited function/disability (U)

3.0

8.5

159

DAX08

NOMESCO Finland

Fitting of hearing aid

1.7

8.5

157

913

N49.9

ICD-10 Finland

Inflammatory disorder of unspecified male genital organ

20.0

8.4

Y83.9

ICD-10 Finland

Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.4

125

677

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

8.4

619

4796

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

2.1

8.4

409

D01

ICPC

Abdominal pain/cramps general

1.4

8.4

409

2973

N06AX12

ATC

bupropion; oral

1.4

8.4

361

2567

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.6

8.4

197

1224

H3600, E113

ICD-10 Finland

2.2

8.4

364

M79.1

ICD-10 Finland

Myalgia

1.3

8.4

520

3933

KDE20

NOMESCO Finland

Removal of foreign body from urethra

2.9

8.4

171

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

3.1

8.3

144

K60.1

ICD-10 Finland

Chronic anal fissure

2.0

8.3

103

521

60401

ICD-8 Finland

Orchitis and epididymitis, Epididymitis acuta

+∞

8.3

60309

ICD-8 Finland

Hydrocele, Unspecified

+∞

8.3

60100

ICD-8 Finland

Prostatitis, Acuta

+∞

8.3

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.4

8.3

326

2276

Y85

ICPC

Benign prostatic hypertrophy

2.4

8.3

288

R13

ICD-10 Finland

Dysphagia

1.5

8.3

260

1734

N50.9

ICD-10 Finland

Disorder of male genital organs, unspecified

3.6

8.3

E10.6

ICD-10 Finland

Type 1 diabetes mellitus, With other specified complications

2.5

8.3

244

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.5

8.3

273

1838

S31.2

ICD-10 Finland

Open wound of penis

4.6

8.2

E10.5

ICD-10 Finland

Type 1 diabetes mellitus, With peripheral circulatory complications

3.1

8.2

140

S17

ICPC

Abrasion/scratch/blister

1.9

8.2

119

640

SGA03

NOMESCO Finland

Demanding opening and dilatation of root canal of tooth

1.3

8.2

566

4348

A10BX01

ATC

guar gum; systemic

1.8

8.2

140

795

6662

FHL

Cholecystectomy

3.0

8.2

146

SPAT1281

SPAT

Other administrative function

1.4

8.2

384

2774

D64.9

ICD-10 Finland

Anaemia, unspecified

1.4

8.2

459

3415

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.3

8.2

779

6250

R4180

NOMESCO Finland

Podiatric therapy

2.5

8.1

241

D82

ICPC

Teeth/gum disease

1.2

8.1

2094

18528

R73.9

ICD-10 Finland

Hyperglycaemia, unspecified

1.8

8.0

140

797

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

2.0

8.0

478

Y88.3

ICD-10 Finland

Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

8.0

117

627

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.4

8.0

432

3191

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.4

8.0

363

2605

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

1.6

8.0

192

1201

C08CA02

ATC

felodipine; oral

1.4

8.0

397

2894

KGD00

NOMESCO Finland

Partial excision of glans penis

22.0

8.0

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

8.0

717

5708

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.3

8.0

614

4787

D01AA02

ATC

natamycin; topical

2.0

8.0

496

M02AA07

ATC

piroxicam; topical

1.2

7.9

1753

15306

L43.8

ICD-10 Finland

Other lichen planus

2.3

7.9

282

R86.0

ICD-10 Finland

Abnormal findings in specimens from male genital organs, abnormal level of enzymes

1.8

7.9

124

683

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

2.3

7.9

314

N03AG01

ATC

valproic acid; systemic, rectal

1.4

7.9

364

2620

S02

ICPC

Pruritus

1.8

7.9

130

730

A08

ICPC

Swelling

1.8

7.9

137

780

C02AC05

ATC

moxonidine; oral

1.6

7.9

219

1420

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

7.9

343

2443

N05CD07

ATC

temazepam; oral

1.3

7.9

535

4098

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.5

7.8

250

1671

S01

ICPC

Pain/tenderness of skin

1.6

7.8

181

1120

WX402

NOMESCO Finland

General anaesthesia

1.2

7.7

862

7041

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

2.5

7.7

235

M14.6*E11.6

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic neuropathic

4.1

7.7

SPAT1059

SPAT

Spirometry at the office

1.5

7.7

223

1460

A41.9

ICD-10 Finland

Sepsis, unspecified

1.6

7.7

185

1157

U71

ICPC

Cystitis/urinary infection other

2.5

7.7

229

WX720

NOMESCO Finland

Own respiration

1.6

7.7

183

1144

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.3

7.6

531

4084

UJF30

NOMESCO Finland

Ileoscopy through colon

1.3

7.6

455

3422

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.7

7.6

154

917

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.6

7.6

171

1051

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

1.9

7.6

104

549

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.2

7.6

871

7136

L30.4

ICD-10 Finland

Erythema intertrigo

2.4

7.6

238

B01AA03

ATC

warfarin; systemic

1.2

7.6

1014

8449

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.4

7.6

333

2376

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.7

7.6

157

944

D01AC03

ATC

econazole; topical

1.4

7.6

319

2260

WX722

NOMESCO Finland

PEEP

1.5

7.6

279

1927

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

7.5

317

2245

F34.1

ICD-10 Finland

Dysthymia

1.7

7.5

160

971

KFB00

NOMESCO Finland

Biopsy of testis

8.8

7.5

Y01

ICPC

Pain in penis

5.4

7.5

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

2.3

7.5

283

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.4

7.5

363

2637

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

1.7

7.5

142

832

A03

ICPC

Fever

1.2

7.5

914

7544

N13.3

ICD-10 Finland

Other and unspecified hydronephrosis

2.0

7.4

431

SFA40

NOMESCO Finland

Replacement of krone of tooth

1.2

7.4

1140

9631

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.2

7.4

1180

10004

R30.1

ICD-10 Finland

Vesical tenesmus

2.3

7.4

297

-50

ICPC

Medication/prescr/renewal

1.6

7.4

185

1171

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.2

7.4

1120

9450

N06AX26

ATC

vortioxetine; oral

1.4

7.3

299

2104

VALMI

NOMESCO Finland

1.2

7.3

1428

12329

359

Kela drug reimbursment

Mirabegroni

5.9

7.3

H02AB04

ATC

methylprednisolone; systemic

1.3

7.3

613

4836

L84

ICD-10 Finland

Corns and callosities

1.7

7.3

151

908

XX3DW

NOMESCO Finland

Time consuming IT work

1.3

7.3

435

3271

6011A

ICD-9 Finland

Inflammatory diseases of prostate, Chronic prostatitis

+∞

7.3

60599

ICD-8 Finland

+∞

7.3

6078X

ICD-9 Finland

Disorders of penis, Other specified disorders of penis[MORBUS PENIDIS ALIUS DEFINITUS]

+∞

7.3

M01AC06

ATC

meloxicam; systemic, rectal

1.2

7.3

1736

15245

KFD16

NOMESCO Finland

Partial excision of epididymis

10.8

7.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

1.8

7.3

111

610

N05BE01

ATC

buspirone; oral

1.6

7.3

164

1011

KCV04

NOMESCO Finland

Distension of bladder with fluid

4.1

7.2

X58

ICD-10 Finland

Exposure to other specified factors

1.2

7.2

964

8028

SPAT1151

SPAT

Treatment of major wounds

2.2

7.2

315

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.5

7.2

216

1427

ZZA00

NOMESCO Finland

Split skin graft

1.6

7.2

162

998

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.3

7.2

462

3515

SPAT1147

SPAT

Destruction of skin lesion with external methods

2.1

7.2

375

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

1.7

7.2

134

784

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

3.0

7.2

132

A63.0

ICD-10 Finland

Anogenital (venereal) warts

1.6

7.1

184

1175

N48.3

ICD-10 Finland

Priapism

29.9

7.1

G04BX04

ATC

2.7

7.1

161

Y05

ICPC

Scrotum/testis sympt/compl other

2.1

7.1

378

DFF00

NOMESCO Finland

Pure tone audiometry

1.4

7.1

386

2859

Z41.2

ICD-10 Finland

Routine and ritual circumcision

20.0

7.1

KGD05

NOMESCO Finland

Partial excision of body of penis

20.0

7.1

C02CA01

ATC

prazosin; oral

2.1

7.1

380

SPAT1101

SPAT

Orthostatic test

1.7

7.0

150

909

N06AB03

ATC

fluoxetine; oral

1.3

7.0

494

3808

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

7.0

258

1781

G63.2*E10.4

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic polyneuropathy

3.2

7.0

106

KCH42

NOMESCO Finland

Transurethral incision or resection of bladder neck

8.7

7.0

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

7.0

412

3091

R55

ICD-10 Finland

Syncope and collapse

1.3

7.0

503

3889

R07.3

ICD-10 Finland

Other chest pain

1.3

7.0

418

3146

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.2

7.0

756

6156

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.5

7.0

199

1300

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.5

7.0

254

1752

C07AA05

ATC

propranolol; systemic

1.2

6.9

866

7162

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

1.7

6.9

127

740

C07AG02

ATC

carvedilol; oral

1.4

6.9

271

1894

M14.6

ICD-10 Finland

Neuropathic arthropathy

4.9

6.9

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.3

6.9

420

3169

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.0

6.9

391

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

2.0

6.9

391

WX725

NOMESCO Finland

Noninvasive ventilation

1.5

6.9

218

1458

L01

ICPC

Neck symptom/complaint

1.3

6.9

485

3741

R21

ICPC

Throat symptom/complaint

1.2

6.9

972

8146

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.5

6.9

201

1320

M03BC01

ATC

orphenadrine (citrate); systemic

1.2

6.9

1233

10567

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

6.9

178

1140

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.7

6.9

133

787

M14.6*E10.6

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic neuropathic

4.6

6.8

L02AE04

ATC

triptorelin; parenteral

2.5

6.8

202

N03AX09

ATC

lamotrigine; oral

1.5

6.8

238

1626

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.3

6.8

485

3745

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.0

6.8

398

SPAT1307

SPAT

Psychosocial counselling and guidance

1.4

6.8

276

1946

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.4

6.8

343

2513

U99

ICPC

Urinary disease other

3.0

6.8

115

A11CC03

ATC

alfacalcidol; systemic

1.7

6.7

121

698

D19

ICPC

Teeth/gum symptom/complaint

1.2

6.7

1417

12310

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

1.6

6.7

178

1145

KGC00

NOMESCO Finland

Partial amputation of penis

16.6

6.7

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

1.7

6.7

123

717

F29

ICPC

Eye symptom/complaint other

1.4

6.7

325

2364

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

6.7

307

2210

K59.0

ICD-10 Finland

Constipation

1.5

6.7

190

1243

N31.2

ICD-10 Finland

Flaccid neuropathic bladder, not elsewhere classified

3.3

6.7

KFH10

NOMESCO Finland

Orchiopexy

4.7

6.7

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.5

6.7

208

1390

25000

ICD-8 Finland

Diabetes mellitus, Sine complicatione

1.7

6.7

119

690

XF400

NOMESCO Finland

ECG with 12 standard connections

1.2

6.7

912

7619

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

1.8

6.6

104

578

C10AC01

ATC

colestyramine; oral

1.9

6.6

519

D16

ICPC

Rectal bleeding

1.9

6.6

519

D02AE01

ATC

carbamide; topical

1.4

6.6

299

2146

CKD65

NOMESCO Finland

Pars plana or pars plicata vitrectomy

1.8

6.6

100

549

K04.1

ICD-10 Finland

Necrosis of pulp

1.3

6.6

624

5004

R15

ICD-10 Finland

Faecal incontinence

2.6

6.6

169

C03DA01

ATC

spironolactone; oral

1.3

6.6

486

3772

J01FA01

ATC

erythromycin; systemic

1.2

6.6

749

6133

P70

ICPC

Dementia

2.2

6.6

284

E78.00

ICD-10 Finland

Familial hypercholesterolaemia

1.5

6.5

182

1184

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.9

6.5

514

N20.1

ICD-10 Finland

Calculus of ureter

1.5

6.5

227

1550

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

2.3

6.5

252

A10BD08

ATC

metformin and vildagliptin; systemic

2.4

6.5

225

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.8

6.5

108

609

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

6.5

153

955

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

2.2

6.5

265

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

6.5

147

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.2

6.5

721

5890

P99

ICPC

Psychological disorders other

1.6

6.5

156

979

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.3

6.5

441

3386

SFA00

NOMESCO Finland

Small filling

1.3

6.5

642

5175

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

1.9

6.5

436

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.3

6.5

442

3396

KCW96

NOMESCO Finland

Other operations on bladder

3.4

6.5

N19

ICD-10 Finland

Unspecified kidney failure

1.6

6.5

154

965

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

1.9

6.4

424

P06

ICPC

Sleep disturbance

1.3

6.4

467

3618

WX199

NOMESCO Finland

Other local analgesia

1.7

6.4

113

651

H3601, E103

ICD-10 Finland

1.9

6.4

467

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.2

6.4

1222

10523

7452

FHL

Transvesical adenoma removal

69.7

6.4

N05AF03

ATC

chlorprothixene; systemic

1.6

6.4

163

1038

K29

ICPC

Cardiovascular sympt/complt other

1.6

6.4

168

1082

M04AA01

ATC

allopurinol; systemic

1.2

6.4

754

6203

KG1AE

NOMESCO Finland

Ultrasound examination of penis

14.3

6.4

M86.9

ICD-10 Finland

Osteomyelitis, unspecified

2.2

6.4

249

EBA10

NOMESCO Finland

Surgical removal of tooth

1.2

6.4

821

6813

D05AX02

ATC

calcipotriol; topical

1.5

6.4

216

1468

N05BA12

ATC

alprazolam; oral

1.3

6.4

435

3340

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

1.6

6.3

159

1009

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

6.3

138

847

SPAT1231

SPAT

Assessment of adjustments needed in living environment

2.0

6.3

344

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.4

6.3

305

2219

E86

ICD-10 Finland

Volume depletion

1.8

6.3

106

602

K80

ICPC

Cardiac arrhythmia NOS

1.4

6.3

248

1740

H3601, E113

ICD-10 Finland

1.9

6.3

480

SGA01

NOMESCO Finland

Tooth opening as first aid

1.2

6.3

1035

8801

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.3

6.2

358

2681

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

6.2

1746

15499

60699

ICD-8 Finland

Sterility, male

+∞

6.2

N43.1

ICD-10 Finland

Infected hydrocele

+∞

6.2

N41.2

ICD-10 Finland

Abscess of prostate

+∞

6.2

6082A

ICD-9 Finland

Other disorders of male genital organs, Torsion of testis

+∞

6.2

6078B

ICD-9 Finland

Disorders of penis, Other specified disorders of penis[IMPOTENTIA ORGANICA]

+∞

6.2

60101

ICD-8 Finland

Prostatitis, Chronica

+∞

6.2

60009

ICD-8 Finland

Hyperplasia of prostate, Unspecified

+∞

6.2

F70

ICPC

Conjunctivitis infectious

1.9

6.2

427

J01MA14

ATC

moxifloxacin; systemic

1.3

6.2

434

3343

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.3

6.2

477

3722

L30.3

ICD-10 Finland

Infective dermatitis

1.6

6.2

169

1093

KCD32

NOMESCO Finland

Cystoscopic destruction of tumour of bladder

2.6

6.2

156

N05CD08

ATC

midazolam; nasal, systemic

1.8

6.2

545

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.4

6.2

199

M01AC01

ATC

piroxicam; systemic, rectal

1.3

6.2

593

4763

N06AX03

ATC

mianserin; oral

1.5

6.2

189

1260

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

6.2

159

1016

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.5

6.2

225

1555

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.4

6.1

322

2378

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

2.5

6.1

183

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.4

6.1

256

1815

H3600, E103

ICD-10 Finland

1.8

6.1

492

K04.0

ICD-10 Finland

Pulpitis

1.2

6.1

624

5051

7501

FHL

Testicular exploration (includes removal of biopsy, detorsion or appendix test)

7.6

6.1

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.3

6.1

424

3267

FPE00

NOMESCO Finland

Implantation of transvenous cardiac pacemaker with ventricular electrode

1.9

6.1

454

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.6

6.1

134

826

K80.1

ICD-10 Finland

Calculus of gallbladder with other cholecystitis

1.9

6.1

441

C09DA03

ATC

valsartan and diuretics; oral

1.5

6.1

205

1396

S08

ICPC

Skin colour change

1.5

6.0

175

1154

M14.6*A52.1

ICD-10 Finland

Charcot's or tabetic arthropathy

3.7

6.0

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.5

6.0

179

1185

L21.9

ICD-10 Finland

Seborrhoeic dermatitis, unspecified

1.8

6.0

102

583

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3026008) Bacteria identified in Urine by Culture

1882

9494

2.20

184.08

3.6

2.5

—

(3002256) Pathology report gross observation

1410

6765

2.25

153.74

1.3

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4788

35635

1.65

125.29

4.7

3.1

e6/l

357.3

664.9

0.50

592

(3037467) Urinalysis macro (dipstick) panel - Urine

5331

41701

1.59

106.58

4.3

3.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

3146

21703

1.65

106.33

4.8

4.2

mg/mmol

13.1

9.5

2.71

2256

15174

(3012516) Albumin [Mass/volume] in Urine

3002

20629

1.64

102.18

3.8

3.4

mg/l

351.5

360.2

0.04

2192

14467

(3009508) Creatinine [Moles/volume] in Urine

3291

23711

1.57

89.16

3.8

3.4

mmol/l

8.7

9.2

5.91

2785

20441

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3254

23990

1.52

76.56

2.1

1.9

pmol/l

91.2

93.3

1.86

1954

13836

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5174

41915

1.48

76.16

4.6

3.6

ug/l

2.7

2.4

0.38

4653

37654

(3013826) Glucose [Moles/volume] in Serum or Plasma

5024

40493

1.47

75.72

6.1

5.3

mmol/l

7.3

6.9

20.37

4762

38282

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7007

60478

1.52

74.05

4.0

3.4

mu/l

2.2

0.13

6434

55703

(3049717) Cytology report of Urine Cyto stain

492

2058

2.45

71.69

2.9

—

(3002582) Erythrocytes [#/volume] in Urine

2645

19025

1.52

68.23

4.0

3.0

e6/l

150.7

107.9

0.34

2116

14595

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8259

74395

1.61

67.69

16.7

12.9

mg/l

26.0

26.2

0.20

6660

57717

(3018095) Leukocytes [#/volume] in Urine

2912

21401

1.50

67.65

4.5

3.4

e6/l

105.6

52.2

2.27

2230

15564

(3019550) Sodium [Moles/volume] in Serum or Plasma

8256

74573

1.60

64.48

19.6

14.9

mmol/l

139.7

0.62

8054

72737

(3023368) Bacteria identified in Blood by Culture

2633

19134

1.50

63.88

5.2

4.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

8288

74981

1.60

63.72

19.7

15.0

mmol/l

4.0

1.24

8072

72989

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3179

24043

1.46

62.90

3.0

2.7

ug/l

176.2

196.5

2.23

2941

22581

(3007853) Bacteria identified in Skin by Aerobe culture

1318

8234

1.68

60.91

2.0

1.8

—

(40761511) CBC panel - Blood by Automated count

8555

78179

1.63

60.89

15.2

11.6

—

(3035350) Ketones [Presence] in Urine by Test strip

3776

29656

1.43

60.38

3.7

2.7

estimate

0.0

0.80

719

5091

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

5522

46433

1.41

59.58

3.2

2.9

pmol/l

14.8

0.46

5000

42410

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3030

22911

1.45

59.19

2.5

2.2

nmol/l

71.1

71.3

0.16

2774

21070

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

6140

52658

1.42

58.79

8.4

7.7

u/l

79.5

79.2

0.19

5833

49976

(3009261) Glucose [Presence] in Urine by Test strip

3786

29929

1.42

57.55

3.7

2.8

estimate

0.0

0.74

662

4920

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

3592

28230

1.42

56.00

4.4

3.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

3739

29619

1.41

55.59

5.0

3.8

estimate

0.0

0.00

749

5368

(3035941) MCH [Entitic mass]

9241

86601

1.86

55.40

23.2

18.0

30.4

2.16

9114

85425

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3842

30601

1.41

55.25

8.7

7.8

mmol/l

1.2

0.09

3244

26004

(3024731) MCV [Entitic volume]

9241

86610

1.86

55.25

23.3

18.0

90.4

90.3

0.26

9113

85427

(3026361) Erythrocytes [#/volume] in Blood

9242

86627

1.86

55.17

23.3

18.1

e12/l

4.7

4.8

4.60

8986

84024

(3000963) Hemoglobin [Mass/volume] in Blood

9245

86669

1.86

55.09

23.5

18.2

g/l

142.9

144.0

8.87

9120

85477

(3010813) Leukocytes [#/volume] in Blood

9242

86659

1.85

54.64

23.4

18.1

e9/l

6.8

6.7

3.48

8990

84086

(3024561) Albumin [Mass/volume] in Serum or Plasma

3589

28290

1.41

54.64

6.2

5.7

g/l

35.7

36.1

3.02

3347

26539

(3007461) Platelets [#/volume] in Blood

9226

86471

1.84

54.51

23.4

18.1

e9/l

237.9

239.1

1.15

9000

84143

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2023

14333

1.51

54.03

2.5

2.2

mg/l

3.0

2.9

0.24

1758

12374

(3013707) Erythrocyte sedimentation rate by Westergren method

5724

48907

1.39

53.27

4.0

3.6

mm/h

11.2

10.1

6.46

5325

45668

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7540

67648

1.45

52.35

7.0

5.2

mmol/mol

42.7

39.9

67.62

7124

63861

(3020564) Creatinine [Moles/volume] in Serum or Plasma

8778

81361

1.62

51.51

18.9

14.5

umol/l

87.7

85.4

5.61

8773

81318

(3030467) Casts [#/volume] in Urine by Automated count

2353

17333

1.46

51.30

3.9

3.0

e6/l

0.4

0.5

1.05

1815

12894

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1755

12191

1.53

51.13

1.8

1.7

pmol/l

37019951.4

29241527.1

0.20

1483

10410

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

4256

34845

1.38

50.35

6.6

umol/l

12.4

12.9

1.25

4062

33278

(3000850) Epithelial cells [#/volume] in Urine

1816

12746

1.51

50.29

3.2

2.5

e6/l

3.1

2.7

1.38

1630

11258

(40768804) Tissue Pathology biopsy report

2895

22292

1.41

49.11

2.0

1.9

—

(3026782) Osmolality of Urine

1709

11920

1.52

48.57

3.3

2.6

mosm/kgh2o

590.7

590.5

0.01

1495

10292

(36304419) Bacteria [Presence] in Urine

2279

16925

1.44

46.90

3.8

2.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2715

20837

1.41

46.40

3.1

2.8

u/l

55.9

58.2

1.55

2521

19488

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8773

81673

1.58

46.20

10.9

9.4

u/l

33.2

33.0

0.17

8503

79438

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

3981

32559

1.36

46.01

4.0

3.2

21.5

22.6

3.75

1580

12061

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

3471

27854

1.37

44.97

8.0

7.2

mmol/l

1.2

0.14

3172

25649

(3021960) Folate [Moles/volume] in Serum or Plasma

1797

12938

1.47

43.07

1.6

1.5

nmol/l

18.8

18.7

0.06

1576

11486

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7620

69290

1.40

42.49

4.6

4.0

mmol/l

6.3

6.0

40.05

7029

64399

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

8279

76416

1.46

42.47

4.9

4.4

mmol/l

2.7

2.8

23.82

7735

71976

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

2995

23693

1.37

41.67

3.8

2.8

—

(3032080) INR in Blood by Coagulation assay

3474

28137

1.35

41.48

10.8

9.1

inr

1.2

1.3

0.85

1063

8050

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7693

70196

1.40

40.97

15.3

11.8

ml/min/173m2

86.3

87.6

4.82

6395

57842

(3019309) Folate [Moles/volume] in Red Blood Cells

1474

10337

1.49

40.04

1.9

1.7

nmol/l

1143.1

1135.6

0.11

1145

8061

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2265

17257

1.40

39.20

3.3

3.2

ng/l

1570.7

1459.8

0.48

1891

14604

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

8167

75470

1.43

39.01

4.5

4.1

mmol/l

4.4

4.6

28.41

7674

71567

(3013650) Neutrophils [#/volume] in Blood by Automated count

4726

40275

1.32

38.93

10.0

10.1

e9/l

4.3

4.2

0.80

4140

35276

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

8122

75030

1.42

38.42

4.4

4.0

mmol/l

1.2

1.3

35.10

7601

70871

(3019069) Monocytes/100 leukocytes in Blood

4018

33511

1.32

38.39

7.1

8.9

9.0

0.69

3796

31866

(3002030) Lymphocytes/100 leukocytes in Blood

4142

34696

1.32

38.36

6.9

6.8

27.3

27.9

2.56

3905

32841

(3019198) Lymphocytes [#/volume] in Blood

4350

36696

1.32

38.29

6.8

6.6

e9/l

1.9

2.0

4.07

3836

32553

(3001604) Monocytes [#/volume] in Blood

4209

35431

1.32

37.26

6.8

6.7

e9/l

0.6

0.24

3652

30914

(3006315) Basophils [#/volume] in Blood

4223

35570

1.32

37.21

6.8

6.7

e9/l

0.0

0.62

3666

31057

(3006504) Eosinophils/100 leukocytes in Blood

3987

33315

1.32

37.21

6.9

6.8

3.1

3.0

2.61

3757

31565

(3013115) Eosinophils [#/volume] in Blood

4332

36657

1.31

36.74

7.1

7.0

e9/l

0.2

1.51

3807

32439

(3018010) Neutrophils/100 leukocytes in Blood

4065

34136

1.31

36.30

6.7

6.6

57.5

57.0

2.09

3840

32467

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

3187

25907

1.33

35.71

4.1

3.3

ng/l

126.8

77.0

0.37

2263

17351

(3022096) Basophils/100 leukocytes in Blood

3879

32419

1.31

35.66

6.9

0.7

0.13

3660

30760

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1408

10031

1.46

34.91

3.6

2.8

e6/l

0.9

0.7

0.95

820

5274

(3044640) Blood type and Crossmatch panel - Blood

2421

18971

1.36

34.46

2.8

2.6

—

(3002385) Erythrocyte distribution width [Ratio]

6933

62868

1.32

33.84

19.8

15.8

13.6

13.5

1.45

6766

61467

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6282

56209

1.30

33.76

3.5

3.2

u/l

55.0

55.2

0.04

5959

53511

(3041096) Erythrocytes [Presence] in Urine by Automated

2179

16860

1.37

33.48

3.4

2.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

552

3189

1.77

33.13

3.5

2.6

e6/l

0.3

0.11

542

3135

(3022948) Iron [Moles/volume] in Serum or Plasma

1446

10450

1.44

33.09

3.0

2.7

umol/l

13.2

13.8

2.15

1343

9861

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1761

13235

1.39

32.19

1.3

u/ml

1.9

0.05

493

3739

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7867

72852

1.36

32.00

4.1

3.7

mmol/l

1.5

1.4

10.60

7340

68642

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1366

9825

1.44

31.99

3.0

2.7

g/l

2.3

0.19

1270

9215

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1464

10666

1.43

31.96

2.0

1.8

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3082

25248

1.31

31.77

3.6

3.5

u/l

33.5

37.4

4.25

2913

23983

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1460

10643

1.43

31.76

3.4

2.6

e6/l

0.9

0.09

872

5879

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1625

12087

1.40

31.50

2.6

2.3

nmol/l

13.7

14.1

1.03

1466

11062

(3009542) Hematocrit [Volume Fraction] of Blood

7906

73319

1.36

31.47

16.5

13.4

42.2

0.15

5975

57974

(3015377) Calcium [Moles/volume] in Serum or Plasma

2404

19082

1.33

30.80

3.5

mmol/l

2.3

1.18

2106

17070

(3029937) Albumin [Presence] in Urine by Test strip

2007

15577

1.35

29.72

4.1

3.1

estimate

0.0

0.00

694

4862

(3044889) 12 lead EKG panel

5632

50097

1.27

29.54

3.8

3.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

2547

20492

1.32

29.44

2.3

2.2

u/l

259.1

291.8

0.80

2393

19418

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1286

9280

1.44

29.40

3.1

2.8

23.7

24.1

0.48

1086

8101

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

2850

23353

1.30

28.65

2.7

2.3

ug/l

0.7

0.58

1662

12750

(42870588) Differential panel, method unspecified - Blood

2925

24095

1.29

28.12

6.5

6.8

—

(3013512) EKG study

2232

17741

1.33

27.86

4.4

3.6

—

(3002032) Base excess in Venous blood by calculation

1032

7235

1.47

27.38

5.2

4.5

mmol/l

1.7

0.03

838

5886

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1032

7258

1.46

26.92

5.2

4.5

kpa

5.9

1.34

994

7038

(3027945) Reticulocytes/100 erythrocytes in Blood

1054

7448

1.46

26.81

2.9

1.7

0.57

942

6718

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1802

14005

1.34

26.01

1.8

1.9

mg/l

1.1

1.3

1.35

1350

10375

(3018418) pH of Serum or Plasma

2231

17882

1.31

25.94

5.3

4.6

7.4

0.24

466

3514

(3012544) pH of Venous blood

1053

7519

1.44

25.27

5.2

4.5

7.4

0.02

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

680

4478

1.55

24.29

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5882

53195

1.25

24.13

3.0

2.8

—

(3048689) Calprotectin [Mass/mass] in Stool

1109

8065

1.41

23.98

3.1

ug/g

188.5

173.9

0.49

923

6776

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

594

3813

1.59

23.73

5.3

5.2

ng/l

117.5

104.2

1.38

534

3420

(3000494) Fungus identified in Specimen by Culture

1106

8060

1.41

23.62

1.6

1.5

—

(3023520) Reticulocytes [#/volume] in Blood

790

5414

1.49

23.37

2.9

e9/l

69.1

71.2

0.89

602

4083

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1032

7447

1.42

23.29

2.0

1.8

—

(3042936) Bacteria identified in Isolate by Culture

1382

10488

1.36

23.05

2.6

2.2

—

(3022145) Colonoscopy Study observation

1023

7404

1.42

22.67

1.4

1.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1022

7406

1.42

22.48

2.0

1.7

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2409

19818

1.28

22.37

2.9

2.8

umol/l

4058.3

4147.2

0.04

2104

17742

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

701

4747

1.51

21.96

4.1

3.7

kpa

5.2

5.1

0.09

664

4391

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1205

9013

1.38

21.95

2.4

2.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

2150

17492

1.28

21.72

1.8

1.7

mmol/l

1.6

1.5

1.61

1802

15012

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1848

14784

1.30

21.19

2.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

171

772

2.23

21.03

1.4

1.3

nmol/l

1.3

1.4

0.36

154

695

(3021589) Normoblasts [#/volume] in Blood

3638

31550

1.23

20.92

11.7

9.8

e9/l

0.0

1.58

2986

25991

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1124

8381

1.38

20.81

2.2

2.0

—

(3022217) INR in Platelet poor plasma by Coagulation assay

1161

8708

1.37

20.72

25.2

23.5

inr

1.4

0.11

183

1288

(3011397) Hemoglobin [Presence] in Urine by Test strip

1662

13146

1.31

20.69

3.7

2.9

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

666

4522

1.50

20.58

4.0

3.6

mmol/l

1.7

1.5

0.98

476

3282

(3036481) Cortisol [Moles/volume] in Serum or Plasma

806

5698

1.44

20.26

2.3

2.4

nmol/l

355.2

365.1

0.74

749

5340

(3007164) IgA [Mass/volume] in Serum or Plasma

1589

12536

1.31

20.10

1.5

g/l

2.7

0.77

1064

8434

(3009343) pH of Capillary blood

683

4686

1.48

20.04

4.1

3.7

7.4

0.71

100

578

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

352

2083

1.71

19.42

2.4

ug/min

142.0

145.0

0.03

231

1316

(3024354) Oxygen [Partial pressure] in Venous blood

823

5885

1.43

19.42

4.4

3.7

kpa

4.8

0.11

784

5680

(3000991) Gas panel - Venous blood

919

6728

1.40

18.94

9.9

10.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

571

3830

1.51

18.70

1.6

1.5

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1251

9643

1.33

18.54

8.1

7.4

mmol/l

1.1

1.0

2.80

1180

9123

(40760892) CBC W Ordered Manual Differential panel - Blood

1983

16262

1.27

18.35

5.3

4.8

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

571

3865

1.50

17.90

2.1

1.9

pmol/l

208.1

217.4

1.40

551

3696

(3014576) Chloride [Moles/volume] in Serum or Plasma

1234

9558

1.33

17.63

8.9

8.5

mmol/l

104.3

104.5

0.66

1196

9363

(3018677) aPTT in Platelet poor plasma by Coagulation assay

1421

11224

1.30

17.62

2.2

2.4

30.3

0.08

1383

10957

(3015235) Bicarbonate [Moles/volume] in Capillary blood

326

1941

1.69

17.61

3.2

3.3

mmol/l

24.2

24.4

0.37

291

1691

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1680

13571

1.28

17.50

4.3

3.7

ng/l

757.2

691.6

0.12

1311

10642

(3003396) Base excess in Arterial blood by calculation

1108

8459

1.34

17.48

8.5

9.0

mmol/l

1.1

0.9

1.28

878

6759

(4146454)

144

656

2.20

17.41

2.4

2.9

—

(40761535) Cells panel - Urine sediment

647

4534

1.45

17.00

3.6

3.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1102

8460

1.33

16.70

8.6

9.0

kpa

11.6

12.4

7.30

1046

8103

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1102

8467

1.33

16.60

8.7

9.0

kpa

5.2

5.1

1.87

1046

8114

(3009214) Lutropin [Units/volume] in Serum or Plasma

419

2700

1.57

16.48

1.6

u/l

4.8

4.9

0.30

342

2209

(3000330) Specific gravity of Urine by Test strip

390

2477

1.59

16.33

4.2

2.9

—

(3016502) Oxygen saturation in Arterial blood

1009

7677

1.34

16.23

8.8

9.5

95.3

95.7

1.26

972

7413

(3021901) Oxygen saturation in Capillary blood

246

1392

1.78

15.96

2.8

2.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

1428

11464

1.28

15.47

4.1

mmol/l

0.8

0.19

1337

10858

(3033658) Prothrombin time (PT) actual/Normal

2205

18632

1.23

15.19

4.9

4.5

87.2

86.6

0.49

2163

18234

(3020779) Urea [Moles/volume] in Serum or Plasma

956

7305

1.33

14.90

9.7

8.9

mmol/l

11.0

9.7

5.65

899

6981

(3028626) Oxygen [Partial pressure] in Capillary blood

304

1859

1.65

14.89

3.7

3.6

kpa

8.3

8.4

0.45

287

1723

(40761536) Microorganisms panel - Urine sediment

677

4908

1.40

14.72

4.5

3.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

872

6585

1.35

14.71

2.4

2.6

g/l

0.2

0.94

814

6105

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

571

4019

1.44

14.66

5.0

mmol/l

23.9

24.0

0.39

526

3636

(3019225) pH of Specimen

713

5220

1.39

14.62

4.6

4.5

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

298

1824

1.65

14.55

2.7

2.3

nmol/l

0.8

0.9

0.51

239

1564

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1051

8168

1.31

14.53

3.8

4.8

u/l

234.4

245.7

1.21

1001

7786

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

734

5413

1.38

14.40

1.9

1.8

nmol/l

34.8

36.6

1.80

719

5303

(3019150) Specific gravity of Urine by Refractometry

1638

13480

1.25

14.31

3.9

3.1

kg/l

1.0

1.26

215

1692

(3017181) Myelocytes/100 leukocytes in Blood

794

5939

1.36

14.25

4.5

1.0

0.9

0.50

244

1750

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

879

6684

1.34

14.14

4.1

3.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

896

6841

1.33

14.02

8.3

8.6

mmol/l

1.5

1.4

0.45

866

6587

(3022621) pH of Urine by Test strip

472

3235

1.47

13.94

2.8

2.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

755

5624

1.36

13.90

4.6

4.5

0.1

0.18

227

1629

(40768443) Skin Pathology biopsy report

387

2556

1.53

13.68

1.3

1.2

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1039

8131

1.30

13.62

3.2

umol/l

9.3

10.0

0.41

914

7256

(3027273) Bicarbonate [Moles/volume] in Venous blood

501

3505

1.45

13.30

5.1

3.7

mmol/l

25.1

0.12

486

3401

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1229

9922

1.27

12.55

3.1

3.4

mmol/l

2.4

0.12

1065

8711

(3002173) Hemoglobin [Mass/volume] in Arterial blood

908

7058

1.31

12.48

9.6

10.1

g/l

125.9

125.7

0.07

871

6829

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

514

3663

1.42

12.35

1.9

1.6

—

(40768797) Stomach Pathology biopsy report

1018

8047

1.29

12.32

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

717

5400

1.35

12.29

4.5

4.2

0.7

0.6

0.22

165

1281

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

449

3143

1.44

11.91

1.6

1.7

g/l

1.6

1.5

0.31

380

2682

(3008152) Bicarbonate [Moles/volume] in Arterial blood

610

4512

1.37

11.75

8.2

8.4

mmol/l

24.8

24.5

1.48

566

4234

(3025159) Blasts/100 leukocytes in Blood

700

5308

1.34

11.46

4.7

4.5

0.6

0.1

0.63

182

1369

(36660697) Celiac disease serology panel - Serum

629

4704

1.35

11.30

1.2

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

641

4810

1.35

11.26

5.3

4.3

mmol/l

1.2

0.28

567

4304

(3027923) C peptide [Moles/volume] in Serum or Plasma

467

2.12

11.14

1.4

1.5

nmol/l

1.1

0.54

369

(3025941) Bacteria identified in Stool by Culture

532

3886

1.38

11.08

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

718

5503

1.32

10.92

3.2

2.9

ng/l

165.1

216.9

3.49

646

4915

(1616796) Gas panel - Central venous blood

273

1758

1.56

10.90

3.8

3.9

—

(3022313) Gas panel - Capillary blood

477

3432

1.40

10.88

4.3

3.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

654

4956

1.34

10.76

8.3

8.6

mmol/l

24.6

24.7

0.28

644

4907

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

234

1460

1.61

10.69

1.1

iu/ml

97.8

94.2

0.04

324

(3004119) Hemoglobin [Mass/volume] in Venous blood

605

4539

1.35

10.65

4.6

3.7

g/l

132.7

133.4

0.35

592

4447

(46235355) HIV 1 and 2 tests - Meaningful Use set

1694

14395

1.21

10.56

2.2

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

890

7063

1.28

10.41

4.5

4.1

29.9

29.5

0.45

637

5165

(3045414) Leukocytes [Presence] in Urine

315

2114

1.50

10.41

1.9

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

393

2756

1.44

10.37

2.4

2.3

—

(3037121) Protein [Mass/volume] in Urine

324

2191

1.49

10.32

3.4

3.9

g/l

0.3

0.07

171

1330

(3000570) Elastase.pancreatic [Mass/mass] in Stool

263

1705

1.55

10.22

1.5

ug/g

255.9

260.6

0.13

153

1026

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

446

3237

1.39

9.69

5.8

4.0

50.8

49.7

0.40

439

3194

(3026389) Candida sp identified in Specimen by Organism specific culture

110

572

1.92

9.53

1.4

1.3

—

(3014051) Protein [Presence] in Urine by Test strip

159

930

1.71

9.38

2.4

2.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

328

2.22

9.34

1.8

1.6

u/ml

21.1

29.3

0.87

(3006184) Hemoglobin [Mass/volume] in Capillary blood

239

1551

1.55

9.28

2.5

2.2

g/l

133.3

136.4

0.90

192

1147

(3019060) Gas panel - Arterial blood

624

4799

1.31

9.28

5.2

5.7

—

(3003338) MCHC [Mass/volume]

7238

69072

1.16

9.27

20.0

15.6

g/l

335.4

336.0

5.65

7168

68500

(3037522) Nuclear Ab [Titer] in Serum

1044

8564

1.24

9.16

1.3

titre

344.9

412.8

1.13

159

1343

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

251

1656

1.52

9.05

1.4

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

392

2820

1.40

9.00

2.2

2.1

ug/l

3.1

2.3

0.39

348

2533

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

113

605

1.87

8.98

1.8

1.7

—

(3019832) Treponema pallidum Ab [Presence] in Serum

663

5168

1.30

8.93

2.3

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

254

1697

1.50

8.65

1.1

u/ml

4.7

5.9

0.33

271

(3021387) Prolactin [Units/volume] in Serum or Plasma

300

2078

1.45

8.52

2.0

1.8

mu/l

277.0

266.9

0.24

278

1948

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

459

3433

1.35

8.30

3.7

3.2

0.6

0.7

0.38

448

3304

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

281

2.24

8.26

1.2

1.3

titre

48.0

113.4

—

(3010421) pH of Blood

296

2061

1.44

8.20

5.4

4.3

7.4

1.07

253

1789

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

292

2.19

7.96

1.3

titre

301.7

604.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

135

795

1.70

7.85

11.7

6.7

mmol/l

8.2

7.6

0.90

116

667

(3003694) ABO and Rh group [Type] in Blood

2148

19038

1.16

7.84

1.3

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

382

2806

1.37

7.78

6.3

6.0

1.0

0.9

0.60

357

2630

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

544

4213

1.30

7.72

11.1

12.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

530

4097

1.30

7.63

2.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

390

2902

1.35

7.34

3.6

2.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

388

2887

1.35

7.30

6.2

5.9

1.8

0.26

360

2707

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

814

6663

1.24

7.29

3.1

2.9

u/l

39.3

66.8

1.29

712

5842

(1761482) Bacteria [#/volume] in Urine by Culture

208

1387

1.50

7.22

5.3

2.9

—

(3047181) Lactate [Moles/volume] in Blood

311

2239

1.39

7.19

6.3

7.2

mmol/l

1.4

1.3

0.06

272

1982

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

328

2385

1.38

7.15

2.0

1.8

—

(3023183) Ammonium ion [Moles/volume] in Plasma

278

1966

1.42

7.13

3.2

3.0

umol/l

34.4

36.1

0.58

223

1696

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

325

2361

1.38

7.12

2.1

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

177

1147

1.55

7.03

3.1

3.4

1.7

1.3

0.53

131

876

(44816559) Phosphatidylethanol [Mass/volume] in Blood

289

2065

1.40

6.99

1.4

1.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

619

4937

1.26

6.98

10.7

11.1

1.4

0.47

613

4903

(3012501) Base excess in Blood by calculation

261

1835

1.43

6.92

5.2

4.2

mmol/l

2.3

2.4

0.11

179

1218

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1489

12947

1.17

6.92

1.5

—

(3013290) Carbon dioxide [Partial pressure] in Blood

261

1836

1.43

6.90

5.2

4.3

kpa

5.1

5.0

0.66

253

1787

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

619

4944

1.26

6.90

10.8

11.3

0.7

0.05

613

4915

(3017143) Hepatitis C virus Ab [Presence] in Serum

1220

10446

1.19

6.83

1.9

1.7

—

(3027315) Oxygen [Partial pressure] in Blood

261

1844

1.42

6.75

5.1

4.2

kpa

8.8

0.17

253

1795

(40767503) Oxygen content in Capillary blood by calculation

234

1622

1.45

6.72

2.9

2.4

16.8

17.1

0.64

136

815

(3000034) Microalbumin [Mass/volume] in Urine

107

619

1.73

6.70

3.7

3.0

mg/l

77.3

55.8

0.37

450

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

525

4134

1.28

6.60

11.2

11.6

mmol/l

24.2

0.04

491

3878

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

4.13

6.49

3.8

1.6

u/field

0.1

0.2

0.73

(3020630) Protein [Mass/volume] in Serum or Plasma

643

5198

1.25

6.47

3.1

2.5

g/l

66.9

67.0

0.01

594

4821

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

333

2469

1.35

6.46

3.7

2.7

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

156

1005

1.55

6.40

1.6

1.7

iu/l

7.7

0.00

121

771

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1200

10322

1.18

6.35

1.7

1.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

399

1.88

6.22

2.1

2.2

ug/min

92.1

131.5

0.50

116

(40758558) Short blood count panel - Blood

1943

17364

1.14

6.14

7.7

7.8

—

(40768800) Prostate Pathology biopsy report

243

1726

1.41

6.14

1.1

1.2

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

385

2941

1.32

6.11

4.8

3.9

mmol/l

24.7

24.6

0.06

366

2754

(3020961) Endomysium IgA Ab [Titer] in Serum

371

2820

1.32

6.11

1.1

titre

103.7

193.2

0.72

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

345

2596

1.33

6.09

2.7

3.6

u/ml

0.3

0.14

182

1459

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

347

1.93

6.03

1.3

1.5

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

347

2618

1.33

6.02

2.2

2.0

—

(3024928) Oxygen saturation in Venous blood

242

1729

1.40

5.93

3.8

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

353

1.90

5.75

1.3

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

553

4458

1.25

5.74

1.8

1.9

g/l

1.2

0.09

513

4096

(3008116) Ketones [Moles/volume] in Urine by Test strip

167

2.33

5.73

1.4

1.6

—

(3037756) Immunofixation for Serum or Plasma

184

1270

1.45

5.48

1.3

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

101

610

1.65

5.48

2.3

2.0

mg/l

33.8

25.0

0.56

162

(3017732) Neutrophils [#/volume] in Blood

550

4460

1.24

5.43

3.0

e9/l

4.2

4.3

0.09

413

3615

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

189

1314

1.44

5.43

1.4

1.3

u/l

20.6

34.4

2.51

166

1156

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

507

1.71

5.39

1.2

mmol/l

12.9

12.5

0.13

228

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

119

752

1.58

5.38

2.3

2.6

nmol/l

20.7

20.3

0.11

113

718

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

360

2783

1.30

5.29

1.2

iu/ml

91.5

117.0

0.96

125

971

(1761868) Lipid panel - Serum or Plasma

3344

31090

1.11

5.21

2.9

2.6

—

(3005570) Glucose [Moles/volume] in Urine

425

1.76

5.15

1.6

1.4

—

70.7

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

261

1938

1.35

5.10

2.7

3.3

ratio

3.1

4.1

0.22

145

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

112

710

1.58

5.03

1.3

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

267

1996

1.34

5.00

2.8

3.4

mg/l

45.3

51.3

0.31

220

1603

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

181

1270

1.43

4.98

1.3

1.4

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.75

4.98

1.1

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

241

1776

1.36

4.96

1.2

1.5

mg/l

661.2

558.4

0.44

227

1701

(3034860) Kappa light chains.free [Mass/volume] in Serum

267

1999

1.34

4.95

2.8

3.4

mg/l

70.5

56.0

1.17

220

1604

(3043410) Blood group antigens tested for on Red Blood Cells

153

2.28

4.95

3.1

1.7

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

212

1531

1.39

4.95

5.6

5.5

umol/l

370.1

371.4

0.05

194

1357

(3035637) Corticotropin [Mass/volume] in Plasma

136

904

1.50

4.94

1.6

1.5

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

667

5573

1.21

4.93

4.2

4.6

ug/l

11.9

30.8

3.56

546

4668

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

106

667

1.59

4.92

1.5

1.6

—

(3003181) Sodium [Moles/volume] in Urine

140

938

1.49

4.90

1.8

1.4

mmol/l

63.8

68.0

0.56

109

727

(3013139) Helicobacter pylori Ag [Presence] in Stool

426

3405

1.26

4.82

1.2

—

(3020891) Body temperature

379

2988

1.27

4.81

6.2

5.5

—

(3052851) Hemolysis interference index of Serum or Plasma

277

2095

1.33

4.81

3.6

3.4

—

(44806420)

162

2.22

4.77

2.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

284

1.90

4.73

2.0

1.7

umol/l

11.0

25.7

11.79

270

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1637

14698

1.13

4.72

2.0

1.5

0.11

1454

13210

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

210

1529

1.37

4.69

1.5

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

201

1455

1.38

4.65

1.4

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

335

2618

1.28

4.58

5.2

4.8

mmol/l

1.4

0.17

328

2579

(3005719) IgG [Mass/volume] in Serum or Plasma

675

5689

1.19

4.56

2.6

g/l

10.9

10.8

0.10

616

5220

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

216

1591

1.36

4.50

1.4

1.6

e6/l

16.4

34.0

0.92

165

1239

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

130

875

1.49

4.48

2.1

2.3

33.1

33.2

0.05

130

870

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

216

1593

1.36

4.47

1.4

1.6

e6/l

1361.1

2324.5

0.30

178

1307

(3018572) Chloride [Moles/volume] in Blood

216

1596

1.35

4.42

7.2

8.6

mmol/l

104.6

105.0

0.64

194

1440

(3039000) Anion gap in Blood

216

1596

1.35

4.42

7.2

8.6

mmol/l

11.5

0.03

194

1440

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

943

8197

1.16

4.38

1.2

u/ml

9.3

12.1

0.71

392

3342

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

339

2670

1.27

4.37

3.2

3.6

pmol/l

4.7

0.11

302

2389

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

402

3233

1.25

4.34

1.1

1.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

523

4329

1.21

4.30

2.3

au/ml

28.2

18.1

0.88

288

(3019977) pH of Arterial blood

392

1.71

4.19

2.7

2.6

7.4

0.01

124

(3003327) Ova and parasites identified in Stool by Light microscopy

283

2192

1.29

4.18

1.6

1.7

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.61

4.18

1.2

1.0

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

3.60

4.17

1.0

1.1

u/ml

0.5

4.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

3.13

4.16

1.4

1.3

umol/24h

316.6

323.6

0.06

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

674

5729

1.18

4.16

2.8

2.5

ml/min/173m2

67.0

70.0

0.79

250

2054

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

291

1.82

4.12

2.3

1.5

u/field

3.4

3.2

0.05

229

(3007566) Smooth muscle Ab [Titer] in Serum

306

2400

1.28

4.11

1.2

1.3

titre

78.1

94.9

0.47

254

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

480

3960

1.22

4.10

1.3

au/ml

47.7

49.6

0.05

167

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

464

1.64

4.06

3.0

2.8

au/ml

127.7

134.4

0.04

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

735

6311

1.17

4.02

2.3

2.2

ug/l

8.4

9.4

0.39

655

5694

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1028

9052

1.15

4.00

1.3

1.2

iu/ml

60.5

38.2

0.27

290

2750

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

175

2.05

3.99

4.3

3.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

239

1826

1.31

3.94

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

118

803

1.47

3.91

2.8

2.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

476

3944

1.21

3.91

1.3

u/ml

423.9

377.3

0.19

442

3677

(3008757) Leukocyte morphology finding [Identifier] in Blood

110

739

1.49

3.89

3.1

4.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

210

1583

1.33

3.82

1.2

1.4

mmol/l

4.1

3.8

2.33

197

1497

(4034850)

272

2128

1.28

3.76

9.7

9.2

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

353

1.70

3.72

2.8

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

140

995

1.41

3.70

5.0

4.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

236

1818

1.30

3.68

1.2

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

323

2587

1.25

3.68

1.6

titre

230.0

383.3

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

192

1438

1.34

3.66

1.9

1.6

—

(3011985) Renin [Units/volume] in Plasma

131

922

1.42

3.66

1.5

mu/l

124.3

86.4

0.75

116

826

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

408

1.64

3.66

2.1

1.8

u/field

3.0

1.2

0.87

182

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

512

1.56

3.57

3.7

3.4

mg/l

8.5

8.1

0.19

424

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

373

1.66

3.55

1.0

1.2

miu/ml

1612.1

1531.6

0.22

373

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

292

2322

1.26

3.55

2.6

3.3

g/l

3.6

0.09

279

2243

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

123

861

1.43

3.55

1.8

1.6

—

(3016038) Potassium [Moles/volume] in Urine

381

1.65

3.54

1.5

1.2

mmol/l

29.9

36.1

1.56

335

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

234

1814

1.29

3.50

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

287

2283

1.26

3.49

1.2

1.3

titre

695.0

1027.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

257

1.79

3.44

2.8

2.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

284

2262

1.26

3.42

5.1

mmol/l

3.9

4.0

0.79

258

2130

(3009445) Proteinase 3 Ab [Units/volume] in Serum

398

3288

1.21

3.41

1.5

1.6

u/ml

13.6

11.5

0.11

121

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

153

1123

1.36

3.37

1.1

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

2.33

3.36

1.1

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

143

1040

1.37

3.33

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

105

723

1.45

3.33

1.9

2.5

—

0.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

151

1108

1.36

3.33

5.9

6.9

mg/l

11.1

10.6

0.92

140

1022

(4035726)

578

4949

1.17

3.32

1.4

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

187

1418

1.32

3.32

1.1

u/ml

1.4

3.0

1.67

401

(3048929) Epstein Barr virus Ab [Presence] in Serum

362

2973

1.22

3.30

1.3

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

358

1.64

3.30

1.2

—

(4024509)

291

1.71

3.27

1.5

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

142

1037

1.37

3.24

1.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

316

2565

1.23

3.24

4.5

4.2

mg/l

1.7

1.4

4.02

288

2400

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

2371

1.24

3.20

2.0

2.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

197

1513

1.30

3.20

2.6

3.3

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

119

846

1.40

3.19

1.4

pmol/l

278.5

262.8

0.19

663

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

294

2373

1.24

3.18

2.0

2.3

g/l

7.5

7.2

1.51

220

1795

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.56

3.17

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

157

1.97

3.14

2.1

1.5

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

561

1.49

3.13

1.5

—

(3008295) Osmolality of Serum or Plasma

612

1.47

3.08

1.4

mosm/kgh2o

283.0

283.9

0.10

500

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

292

2367

1.23

3.05

2.0

2.3

g/l

4.1

4.0

0.43

210

1723

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

250

1993

1.25

3.03

1.2

1.3

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

125

2.07

3.03

4.1

2.2

mmol/l

7.6

8.6

0.46

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

352

2916

1.21

2.98

2.5

2.6

ug/l

442.2

720.7

1.22

333

2785

(3022689) Creatine [Moles/volume] in Urine

203

1.82

2.97

1.2

1.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

1.78

2.95

2.9

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

1.78

2.95

2.9

2.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

140

1.99

2.95

5.9

9.5

mmol/l

7.0

6.1

0.44

140

(3017354) Segmented neutrophils/100 leukocytes in Blood

101

709

1.42

2.94

3.2

56.3

59.5

0.53

444

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

237

1887

1.26

2.92

1.3

u/ml

242.4

244.8

0.05

147

1214

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

2.45

2.92

1.1

u/ml

0.0

0.5

—

(4010399)

543

4679

1.16

2.92

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

402

1.56

2.91

1.4

1.6

nmol/l

0.1

0.53

334

(3051593) INR in Capillary blood by Coagulation assay

271

1.69

2.91

12.9

9.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

185

1430

1.29

2.90

1.1

u/ml

1.4

1.3

0.03

692

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

232

1845

1.26

2.89

1.3

1.5

g/l

0.2

0.18

217

1761

(3044242) Glucose [Moles/volume] in Arterial blood

326

1.62

2.86

2.2

2.0

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

239

1911

1.25

2.85

1.3

1.5

g/l

1.2

1.35

223

1828

(3044007) Cell count panel - Peritoneal fluid

221

1.76

2.84

2.3

1.9

—

(3000012) Reticulocyte production index

358

1.59

2.83

1.5

1.6

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

104

741

1.40

2.80

1.3

1.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

376

3157

1.19

2.78

1.3

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

223

1.74

2.76

1.7

1.9

—

(3004775) Volume in Urine collected for unspecified duration

677

1.42

2.75

2.2

2.4

652.3

691.4

0.51

474

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

273

2226

1.23

2.74

2.0

2.4

g/l

3.1

0.31

215

1769

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

194

1523

1.27

2.72

1.5

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

194

1523

1.27

2.72

1.5

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

129

958

1.34

2.71

1.1

—

(3021788) Differential panel - Synovial fluid

165

1270

1.30

2.70

1.5

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

262

2132

1.23

2.69

1.4

iu/ml

15.2

5.8

—

(21494890) Protein electrophoresis panel - 24 hour Urine

102

731

1.39

2.67

1.6

2.0

—

(3041806) Other cells [#/volume] in Blood by Manual count

340

1.58

2.67

1.5

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

101

723

1.39

2.67

1.3

1.5

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

222

1777

1.25

2.65

1.7

1.8

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

226

1.72

2.65

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

266

2174

1.22

2.62

1.7

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

127

948

1.34

2.59

2.7

2.6

nmol/l

0.8

0.06

100

690

(3014133) Dog dander IgE Ab [Units/volume] in Serum

153

1174

1.30

2.58

1.0

1.1

u/ml

5.5

4.4

0.26

543

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

115

850

1.35

2.52

1.3

—

(3044941) Cell count panel - Synovial fluid

144

1100

1.31

2.52

1.5

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

322

1.58

2.51

1.4

u/l

6.7

10.0

2.44

270

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

130

979

1.33

2.51

1.1

u/ml

2.5

3.2

0.28

527

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

164

1275

1.28

2.51

1.8

1.9

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

134

1014

1.32

2.51

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

109

800

1.36

2.50

1.3

1.5

titre

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

157

1.84

2.48

1.2

1.4

ng/l

25.1

107.5

2.60

106

(3028300) Cannabinoids [Presence] in Urine

681

6038

1.13

2.47

2.4

2.6

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

215

1731

1.24

2.46

1.7

1.9

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

100

726

1.37

2.46

1.3

1.5

—

(3016018) Differential panel - Cerebral spinal fluid

107

786

1.36

2.45

1.4

1.6

—

(3027008) Opiates [Presence] in Urine

679

6024

1.13

2.45

2.3

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

668

1.39

2.44

2.5

3.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

413

1.50

2.42

3.9

3.7

mu/l

27.4

32.8

0.46

382

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

102

747

1.36

2.39

1.2

1.3

nmol/l

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

604

1.40

2.38

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

335

1.55

2.37

1.1

iu/ml

4.4

8.5

1.60

(3025468) Yersinia sp identified in Specimen by Organism specific culture

714

1.37

2.37

1.3

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

351

1.53

2.37

3.1

1.7

umol/l

122.0

128.0

0.03

156

(3027944) Amphetamines [Presence] in Urine

668

5934

1.13

2.37

2.2

2.5

—

(3052592) Norovirus Ag [Presence] in Stool

124

1.93

2.36

1.3

1.6

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

715

1.37

2.35

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

715

1.37

2.35

1.3

1.5

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

556

1.42

2.34

1.3

mmol/l

2.1

2.0

0.07

520

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

282

1.59

2.31

1.2

1.6

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

282

1.59

2.31

1.2

1.6

—

(3000764) Benzodiazepines [Presence] in Urine

671

5982

1.12

2.25

2.4

2.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

200

1.69

2.23

2.5

2.2

umol/l

36.1

20.2

0.35

153

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

267

2224

1.20

2.23

2.0

2.4

g/l

10.3

10.6

0.49

230

1892

(1002224) Polysomnography panel

515

4522

1.14

2.21

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

202

1638

1.23

2.21

1.1

u/ml

1.6

2.1

0.23

796

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

870

7880

1.11

2.20

8.0

6.7

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

390

1.48

2.20

1.0

ng/l

847.3

792.3

0.33

261

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

390

1.48

2.20

1.0

ng/l

42.9

38.6

0.17

260

(3016879) Cocaine [Presence] in Urine

637

5675

1.13

2.18

2.4

2.6

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

303

1.55

2.16

2.4

2.7

ug/l

1.0

0.9

0.24

274

(3013293) Extractable nuclear Ab [Presence] in Serum

2.61

2.16

1.4

1.7

—

(3000285) Sodium [Moles/volume] in Blood

2.12

2.15

1.0

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

392

1.48

2.15

1.0

ng/l

262.1

284.8

0.43

270

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

458

1.44

2.14

1.5

—

(3045424) Erythrocytes [Presence] in Urine

119

910

1.31

2.12

1.3

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

139

1088

1.28

2.08

1.0

u/ml

7.4

5.6

0.36

518

(3029634) Reagin Ab [Titer] in Serum by VDRL

186

1506

1.23

2.08

3.6

2.9

titre

16.2

7.3

0.46

(3003888) Timothy IgE Ab [Units/volume] in Serum

186

1506

1.23

2.08

1.1

u/ml

7.6

7.7

0.02

117

881

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

404

1.46

2.06

1.5

—

(3004451) EKG impression Narrative

324

1.51

2.03

1.2

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

206

1.65

2.03

7.7

6.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

3.98

2.03

1.3

1.0

mmol/24h

1.5

2.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

399

1.45

1.99

1.6

1.5

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

118

1.86

1.98

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

233

1942

1.20

1.97

1.3

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

2.02

1.93

1.1

1.2

u/l

215.6

450.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

111

854

1.30

1.92

1.2

1.3

nmol/l

0.1

0.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

353

1.47

1.92

2.1

2.2

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

271

2297

1.18

1.91

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

219

1824

1.20

1.88

1.2

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

517

4601

1.12

1.84

2.6

2.8

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.97

1.82

2.7

3.6

mg/l

0.7

1.3

0.96

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

239

2015

1.19

1.81

2.3

2.6

g/l

0.3

1.0

5.48

214

1750

(3030313) Adrenal Ab [Titer] in Serum

2.33

1.75

1.4

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

402

1.41

1.75

2.1

umol/l

22.1

42.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

228

1921

1.19

1.75

1.2

u/ml

0.3

0.4

0.64

166

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

320

1.46

1.74

2.5

3.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

161

1314

1.22

1.73

1.6

1.5

—

(3019230) Fractional oxyhemoglobin in Venous blood

177

1460

1.21

1.71

4.1

3.4

68.8

66.8

0.66

177

1450

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

266

2275

1.17

1.71

3.3

4.1

u/ml

391.6

2586.1

1.10

240

1983

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

147

1.69

1.70

2.5

2.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

122

968

1.26

1.70

1.0

u/ml

1.0

0.9

0.06

246

(3014271) Vancomycin [Susceptibility]

281

1.49

1.70

3.4

2.8

—

(40757373) Influenza virus identified in Isolate

140

1.71

1.68

1.6

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

100

775

1.29

1.68

1.2

1.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

197

1645

1.20

1.68

1.6

—

(3002619) Bacteria identified in Specimen by Culture

133

1.72

1.67

1.3

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

250

1.51

1.66

1.7

2.1

e6/l

10600.5

10460.9

0.00

144

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

382

1.41

1.65

1.1

—

50.2

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

283

1.48

1.65

1.9

2.2

e6/l

2478.7

3390.6

0.12

202

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

188

1.59

1.62

1.4

1.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

218

1844

1.18

1.62

2.1

2.4

g/l

37.0

38.1

1.44

194

1612

(3026470) Cobalt [Mass/volume] in Blood

367

1.41

1.61

2.0

1.8

ug/l

8.3

3.0

0.74

315

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

217

1837

1.18

1.60

2.1

2.4

g/l

0.1

0.0

0.28

206

1674

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

215

1819

1.18

1.60

1.3

1.2

miu/ml

169.1

199.1

0.61

664

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

128

1.71

1.57

1.1

1.5

105.9

104.2

0.09

123

(3028717) Thiamine [Mass/volume] in Blood

1.94

1.57

1.5

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

295

1.45

1.56

1.7

2.1

—

(3025577) Chromium [Mass/volume] in Blood

353

1.41

1.56

2.1

1.9

ug/l

3.5

1.8

0.90

298

(3044927) Protein electrophoresis panel - Urine

523

1.33

1.55

1.2

—

(44813793)

379

1.39

1.54

1.0

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

123

990

1.24

1.54

1.4

—

(3020491) Glucose [Moles/volume] in Blood

493

1.33

1.48

1.5

1.8

mmol/l

7.8

7.3

0.48

356

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

146

1.64

1.48

2.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

408

1.37

1.47

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

686

1.28

1.46

4.4

4.1

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

139

1.65

1.45

1.3

pmol/l

281.9

273.6

0.04

104

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

384

1.38

1.44

1.3

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

270

2348

1.15

1.44

3.7

4.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

470

1.34

1.43

1.0

1.1

u/ml

0.7

3.6

1.00

126

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

2.24

1.39

1.0

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

103

1.74

1.38

1.1

1.2

—

(3045788) Cell count panel - Pleural fluid

692

1.27

1.38

1.7

1.5

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

350

3110

1.12

1.36

2.2

2.1

u/l

38.9

39.5

0.19

302

2786

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

296

1.41

1.36

1.2

u/ml

7.9

24.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

123

1008

1.22

1.34

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

112

1.69

1.33

1.3

1.4

15.3

11.6

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

2.12

1.32

1.1

1.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.03

1.31

1.5

1.7

mg/l

1.1

2.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.03

1.31

1.5

1.7

mg/l

1.0

4.4

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.03

1.31

1.5

1.7

mg/l

0.5

1.2

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

199

1707

1.16

1.31

2.1

2.5

g/l

0.0

0.25

188

1546

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

274

1.42

1.29

1.9

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

125

1031

1.21

1.29

1.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

197

1691

1.16

1.29

1.9

1.6

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

621

1.27

1.26

1.4

1.5

umol/l

66.6

79.2

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

147

1234

1.19

1.26

2.7

2.3

titre

3030.6

3720.7

0.17

112

(43055514) Macroprolactin [Presence] in Serum or Plasma

145

1.58

1.26

1.9

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

185

1.51

1.26

1.7

1.9

umol/l

16.7

16.2

0.08

185

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

719

1.25

1.26

1.2

1.1

mg/l

268.5

271.3

0.18

660

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

144

1207

1.19

1.26

1.2

u/ml

22.0

9.5

0.44

149

(37021550) Renin [Units/volume] in Plasma --upright

122

1.63

1.25

1.4

mu/l

97.7

126.7

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

174

1484

1.17

1.24

1.1

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

465

1.31

1.23

1.1

—

(3036489) Thrombin time

327

2915

1.12

1.23

2.2

2.6

22.2

21.6

0.44

292

2590

(3020393) Adenovirus Ag [Presence] in Stool

1.73

1.23

1.5

1.3

—

(3016750) Collection duration of Urine

492

1.30

1.22

2.3

min

500.0

496.7

0.10

381

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

964

9027

1.07

1.21

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

116

957

1.21

1.6

1.7

iu/l

6.8

3.9

0.79

305

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.62

1.21

1.0

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

389

1.33

1.20

6.0

5.6

u/ml

126.6

67.4

0.23

130

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

235

2056

1.14

1.20

1.4

1.2

—

(3033799) Differential panel - Peritoneal fluid

245

1.42

1.20

2.2

2.1

—

(3011412) CD3 cells [#/volume] in Blood

778

1.23

1.19

2.8

2.7

e9/l

1.0

1.1

1.19

455

(3038177) Helicobacter pylori Ab [Presence] in Serum

138

1159

1.19

1.3

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

842

1.22

1.18

1.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

195

1686

1.15

1.18

2.1

2.5

g/l

0.0

0.00

187

1544

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

339

1.35

1.18

3.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

426

1.31

1.16

2.3

—

(3036525) Urea [Moles/time] in 24 hour Urine

1.87

1.16

3.2

2.8

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

160

1365

1.17

1.16

1.5

1.7

g/l

0.9

0.00

123

1036

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

1.15

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

109

899

1.21

1.15

1.2

u/ml

53.7

38.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

120

999

1.20

1.15

1.2

u/ml

21.8

4.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

291

2589

1.12

1.15

2.3

2.8

92.5

90.3

1.02

277

2467

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

541

1.27

1.15

1.4

u/l

13.1

12.5

0.36

524

(3049242) von Willebrand panel - Platelet poor plasma

2.49

1.14

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

141

1193

1.18

1.13

1.2

u/ml

4.5

7.8

0.46

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

622

1.25

1.13

1.4

1.2

u/l

62.4

77.0

1.01

429

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.72

1.13

1.0

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

368

1.33

1.12

1.7

1.6

u/l

7.2

5.5

0.26

192

(21494815) CD4 cells/100 lymphocytes in Specimen

101

830

1.21

1.12

2.8

2.4

40.3

37.8

0.24

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

139

1178

1.18

1.10

1.2

1.3

—

(3020650) Glucose [Presence] in Urine

183

1.47

1.10

1.4

1.2

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

183

1.47

1.10

1.5

1.3

g/l

26.1

23.3

0.34

137

(3021879) Hepatitis B virus core Ab [Presence] in Serum

740

6893

1.07

1.10

1.6

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

133

1123

1.18

1.10

1.4

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

405

1.30

1.08

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

2.18

1.07

1.0

u/ml

11.7

42.4

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

302

1.35

1.07

2.3

2.0

umol/l

1.9

2.0

0.03

283

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

197

1721

1.14

1.06

1.2

1.3

pmol/l

80.9

155.4

0.65

456

(4198724)

754

1.22

1.06

2.3

2.7

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

1.86

1.06

3.2

2.1

umol/l

1.5

1.2

1.68

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

222

1957

1.13

1.05

7.8

6.2

iu/ml

2807.5

3995.0

0.16

296

(3011648) Oxygen content in Venous blood

674

1.23

1.05

2.8

3.2

11.9

11.6

0.24

674

(3035947) Staphylolysin Ab [Units/volume] in Serum

417

1.29

1.03

1.2

1.1

iu/ml

4.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

497

1.26

1.03

1.4

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

748

1.21

1.03

2.8

3.3

nmol/l

6.8

6.7

0.02

729

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.05

1.02

1.3

2.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

220

1.40

1.02

3.9

5.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

237

1.39

1.01

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

570

1.24

1.00

13.1

12.0

mmol/l

0.6

0.42

529

(3024869) Neuronal Ab [Presence] in Serum

122

1.55

1.00

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.87

1.00

1.1

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

293

2636

1.11

0.99

1.7

1.6

iu/ml

0.1

3.0

0.73

557

(3006270) Folate [Moles/volume] in Blood

465

1.26

0.98

1.1

1.2

nmol/l

325.7

371.2

0.92

385

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.52

0.97

1.2

1.3

61.1

79.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

131

1.52

0.97

1.2

1.4

89.2

85.1

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

137

1175

1.16

0.97

1.3

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

220

1950

1.13

0.97

1.4

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.97

0.0

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

206

1.40

0.96

1.3

1.5

ug/l

9.4

9.2

0.10

206

(3045716) Anion gap in Serum or Plasma

326

1.31

0.96

6.5

1.9

mmol/l

9.3

9.2

0.07

243

(3024471) HLA-A [Type]

405

1.28

0.95

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

255

2283

1.11

0.95

2.6

3.1

194.5

191.9

0.20

245

2198

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

198

1.41

0.95

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.84

0.95

2.5

1.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.84

0.95

1.3

1.1

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

1.73

0.95

2.7

60.2

54.3

—

(40768446) Kidney Pathology biopsy report

432

1.27

0.95

1.9

1.8

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

108

1.57

0.94

2.2

2.0

ng/l

149.2

167.7

0.11

108

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

275

1.34

0.94

1.0

1.2

—

(4038314)

207

1.40

0.94

1.2

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

157

1.46

0.94

1.0

—

(4133840)

350

0.71

0.93

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

380

1.28

0.93

1.1

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

1.77

0.92

1.4

1.2

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

207

1835

1.13

0.92

1.6

—

(3036603) Volume of Urine

470

1.25

0.91

1.8

1.9

1918.0

2143.7

—

104

(3003740) Influenza virus B Ag [Presence] in Specimen

188

1659

1.13

0.91

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.81

0.90

2.5

1.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

382

1.28

0.90

1.7

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

123

1055

1.16

0.89

1.1

au/ml

4.3

11.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.62

0.89

1.1

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

366

1.28

0.88

2.2

2.3

mg/l

7.5

9.3

1.26

297

(3051387) C reactive protein [Mass/volume] in Capillary blood

168

1477

1.13

0.87

3.8

2.8

mg/l

30.9

30.3

0.08

109

962

(3012494) Peanut IgE Ab [Units/volume] in Serum

185

1.40

0.87

1.0

1.1

u/ml

2.3

7.2

0.56

105

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.99

0.86

1.0

—

(3019174) dRVVT (LA screen)

1.78

0.86

1.4

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

394

1.26

0.86

1.3

u/l

245.0

431.8

1.71

360

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

123

1060

1.16

0.85

1.2

—

30.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

203

1.37

0.85

1.0

1.3

g/l

0.3

0.40

165

(3009677) Dengue virus Ab [Presence] in Serum

1.93

0.84

1.0

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

273

1.31

0.83

2.7

umol/l

29.5

28.6

0.19

192

(3025315) Body weight

1.58

0.82

4.2

4.0

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

256

1.32

0.82

8.5

7.8

—

(3002523) Influenza virus A Ag [Presence] in Specimen

187

1663

1.12

0.82

1.0

1.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.87

0.81

3.8

6.4

—

(21494755) Public health laboratory ask at order entry panel

1165

12083

0.95

0.80

1.3

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

389

1.26

0.80

1.0

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

354

1.27

0.80

1.2

1.1

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

1.54

0.79

1.1

1.2

mmol/l

0.3

1.3

—

(3023419) Bacteria identified in Sputum by Culture

103

882

1.16

0.79

2.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

680

1.19

0.79

3.7

3.9

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

172

1.39

0.78

1.1

1.2

83.3

82.3

0.05

102

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.72

0.78

1.4

1.2

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

147

1.42

0.78

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

147

1.42

0.78

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

147

1.42

0.78

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

147

1.42

0.78

1.0

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

342

3146

1.08

0.77

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

141

1238

1.14

0.77

1.1

g/l

1.4

1.5

0.73

128

1132

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.66

0.77

2.0

2.2

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.50

0.77

4.2

2.2

—

(3024932) HLA-DR beta [Type]

401

1.24

0.76

1.1

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

120

1043

1.15

0.76

1.6

1.5

promille

1.6

1.5

0.31

800

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.16

0.76

1.6

1.2

nmol/l

284.9

649.7

—

(3051651) Icteric interference index of Serum or Plasma

474

1.22

0.75

5.0

4.5

—

(3003434) Protein [Mass/volume] in Pleural fluid

114

989

1.15

0.75

1.6

1.5

g/l

31.9

33.7

0.72

100

883

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

1.69

0.74

1.3

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

296

1.28

0.74

1.9

1.8

au/ml

106.7

106.3

0.00

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

566

1.20

0.74

2.7

2.3

—

(3017569) Oxygen content in Arterial blood

314

1.27

0.73

2.5

2.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.53

0.73

2.3

2.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

166

1.38

0.73

1.1

1.3

82.3

78.7

0.19

100

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

649

1.18

0.73

1.1

—

(3000093) Morphology [Interpretation] in Blood Narrative

741

1.17

0.73

1.2

—

(3042517) Benzodiazepines panel - Urine

183

0.65

0.73

5.8

3.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

350

1.25

0.73

1.2

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

285

2611

1.09

0.72

1.7

mg/l

2.9

3.7

0.95

205

1757

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

540

1.20

0.72

1.1

—

(3023410) Appearance of Cerebral spinal fluid

742

1.17

0.72

1.6

1.9

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

650

1.18

0.72

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

696

1.17

0.72

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

298

1.27

0.71

1.0

—

(4281824)

219

1.32

0.71

1.4

1.3

—

(3046861) Legionella sp Ag [Presence] in Urine

1.74

0.71

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

159

1.38

0.70

2.1

2.5

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.91

0.70

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

185

1.35

0.70

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

185

1.35

0.70

1.0

1.2

—

(4027681)

497

1.20

0.69

1.3

—

(3011288) Drugs identified in Urine by Screen method

407

3790

1.07

0.69

3.6

4.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.70

0.69

1.9

1.7

umol/l

37.1

46.0

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

109

1.46

0.69

1.2

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

617

1.18

0.68

2.5

2.3

14.2

14.6

0.12

307

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

186

1.34

0.68

1.0

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

207

1877

1.10

0.67

1.8

1.5

u/ml

16.8

21.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

265

1.28

0.67

1.2

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.52

0.67

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

412

3845

1.07

0.67

1.9

1.7

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

155

0.64

0.66

1.0

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

409

1.22

0.66

1.1

1.2

ratio

1.1

0.38

139

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.62

0.66

6.4

4.4

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.62

0.66

6.6

4.7

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

579

0.82

0.65

3.6

2.7

39.2

36.3

0.30

180

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

258

1.27

0.64

1.2

—

(3042733) HLA Ab [Presence] in Serum

430

1.20

0.63

4.9

4.8

—

(3035880) pH of Pleural fluid

421

1.21

0.63

1.4

1.3

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

120

1.41

0.63

1.1

1.5

—

10.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

725

1.15

0.62

1.7

—

(3036670) Protein [Mass/volume] in Synovial fluid

199

0.70

0.62

1.2

g/l

43.6

41.6

—

112

(3001019) Free T4 and TSH panel - Serum or Plasma

346

3221

1.07

0.62

1.3

1.4

—

(40768806) Pleura Pathology biopsy report

763

1.15

0.62

1.7

1.6

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

101

0.59

0.62

8.0

7.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

332

1.23

0.61

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

634

1.16

0.61

1.2

mg/l

47.7

50.5

0.16

542

(3026692) Albumin [Mass/volume] in Peritoneal fluid

225

1.28

0.61

1.3

1.6

g/l

11.4

12.4

0.19

168

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

423

1.20

0.61

1.3

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

121

1.40

0.60

1.1

1.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

183

1662

1.10

0.60

1.6

e6/l

16678.1

15271.6

0.15

121

1204

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

140

0.64

0.60

1.3

1.1

—

(3015183) Erythrocyte sedimentation rate

415

1.20

0.59

1.2

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.47

0.59

2.0

1.5

mmol/l

202.0

182.7

0.17

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

591

1.16

0.58

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.52

0.58

2.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

206

1886

1.09

0.58

1.8

1.6

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

183

1.31

0.57

1.3

101.6

87.1

1.11

171

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

353

1.21

0.57

1.0

1.1

nmol/l

1.2

4.8

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

103

909

1.13

0.57

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

426

1.19

0.57

1.3

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

114

1.40

0.57

1.7

1.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.45

0.56

1.0

1.2

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

175

1.31

0.56

1.1

1.2

—

(3011897) Casein IgE Ab [Units/volume] in Serum

106

1.41

0.56

1.1

1.3

u/ml

1.0

6.7

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.57

0.56

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

211

1.27

0.55

1.1

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

115

1.39

0.55

1.1

1.2

mmol/l

1.5

1.6

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

178

1624

1.09

0.55

1.1

—

(44790049)

875

1.13

0.55

1.8

1.6

—

(44806118)

875

1.13

0.55

1.8

1.6

—

(44790047)

875

1.13

0.55

1.8

1.6

—

(44790048)

875

1.13

0.55

1.8

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

577

1.16

0.54

1.8

1.6

iu/ml

2183645.1

2188104.5

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

311

1.22

0.53

1.1

ng/l

790.3

295.5

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

230

1.26

0.53

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

177

1.29

0.53

1.2

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

1.48

0.52

1.0

1.2

—

(4062490)

813

1.13

0.52

1.3

1.4

—

(3000492) Spirometry study

930

8944

1.04

0.52

1.5

1.4

—

(3042631) Mycobacterium sp identified in Specimen

111

993

1.11

0.51

2.5

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

441

1.17

0.51

1.0

u/ml

0.7

1.8

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

205

1.26

0.50

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

100

1.39

0.50

1.1

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

232

1.24

0.50

1.4

2.0

3.4

0.53

197

(3024139) IgG subclass 3 [Mass/volume] in Serum

816

1.12

0.50

1.2

1.4

g/l

0.4

1.56

543

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

179

1.28

0.49

1.2

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

109

1.37

0.49

3.3

5.6

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

817

1.12

0.49

1.2

1.4

g/l

6.7

6.9

0.31

546

(3028192) IgG subclass 2 [Mass/volume] in Serum

817

1.12

0.49

1.2

1.4

g/l

3.0

0.10

546

(3014599) Egg white IgE Ab [Units/volume] in Serum

481

1.16

0.48

1.0

1.1

u/ml

4.3

2.6

0.27

125

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

481

1.16

0.48

5.0

5.3

u/l

4.5

2310.4

0.51

(40768441) Liver Pathology biopsy report

565

1.15

0.48

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

136

1.32

0.47

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

371

1.18

0.47

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

371

1.18

0.47

1.7

—

(3001729) Color of Synovial fluid

1.45

0.46

1.3

1.5

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

539

1.15

0.46

1.4

1.3

u/l

18.0

14.9

0.40

501

(4306422)

131

1192

1.10

0.46

1.2

—

(3017704) Immunofixation for Urine

336

1.19

0.45

1.2

1.6

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

209

1.24

0.44

1.1

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

267

2502

1.06

0.44

2.9

2.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

106

956

1.10

0.44

1.1

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

174

0.74

0.44

12.7

8.5

—

(3001556) Androgen free Index in Serum or Plasma

103

1.35

0.44

1.3

1.7

—

(3004616) Nuclear Ab [Presence] in Serum

617

1.13

0.43

1.3

1.2

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

246

1.21

0.43

1.0

1.1

u/ml

11.3

9.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

721

1.12

0.43

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

112

1.33

0.43

1.1

umol/24h

0.8

12.0

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

403

1.16

0.43

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

403

1.16

0.43

1.2

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.36

0.42

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

104

1.34

0.42

1.0

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

222

2075

1.07

0.41

2.3

2.1

mg/l

11.3

10.7

0.42

208

1960

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.37

0.41

1.1

1.6

—

(3046914) Granular casts [#/area] in Urine by Computer assisted method

0.00

0.41

0.0

1.7

—

0.8

—

(3011544) Albumin [Mass/volume] in Pleural fluid

1.35

0.40

1.1

1.2

g/l

17.2

16.1

—

(3040893) Potassium [Moles/volume] in Capillary blood

1.42

0.39

1.6

2.4

mmol/l

4.2

4.5

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

5.6

—

5.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

141

1.27

0.39

1.0

1.4

umol/l

3.1

4.7

1.54

129

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1068

0.91

0.38

2.2

2.4

13.0

0.05

1051

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

1.40

0.38

4.9

2.7

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

1.38

0.38

1.0

1.1

u/ml

2.1

12.5

—

(3009871) Measles virus Ab [Titer] in Serum

297

1.17

0.37

1.7

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

188

1756

1.07

0.37

1.8

1.6

u/ml

102.2

108.8

0.37

342

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

279

1.18

0.37

2.0

2.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

299

0.83

0.37

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

645

1.11

0.36

1.4

1.3

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

201

0.79

0.36

1.4

1.3

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

116

1.29

0.36

2.7

2.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

328

3119

1.05

0.36

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

181

1692

1.07

0.35

1.1

—

(3036782) Glucose [Moles/volume] in Pleural fluid

713

1.10

0.35

1.5

1.4

mmol/l

6.9

6.2

1.09

657

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

271

1.18

0.35

1.4

1.6

nmol/l

82.5

4.5

0.51

231

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

609

1.11

0.35

1.1

mg/l

335.0

332.7

0.02

545

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

198

1.21

0.35

1.0

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

1.39

0.35

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

724

1.10

0.34

1.5

1.6

30.9

26.9

0.43

482

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

127

1174

1.08

0.34

1.4

1.3

u/ml

4.2

3.9

0.11

584

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

272

1.17

0.34

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.31

0.34

1.2

—

(4015189)

171

1.22

0.34

4.2

2.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

162

1.23

0.34

1.3

2.9

—

(40768793) Breast Pathology biopsy report

1.36

0.34

1.2

1.1

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

1.3

u/ml

0.5

3.6

—

(3011325) HIV 1+2 Ab [Presence] in Serum

1.36

0.34

1.0

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

403

1.14

0.34

1.2

1.1

—

(3028433) Virus identified in Specimen by Culture

245

1.18

0.33

1.4

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

310

1.16

0.33

2.6

2.0

umol/l

24.2

26.9

0.97

297

(3005011) Chlamydia sp Ab [Titer] in Serum

0.69

0.33

1.7

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

100

1.29

0.32

1.1

1.3

53.1

52.8

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

663

0.90

0.32

1.3

e6/l

125484.3

90402.4

0.17

454

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

209

1.19

0.32

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

804

1.09

0.32

1.2

—

(3003577) Lead [Moles/volume] in Blood

128

1.24

0.30

2.0

1.4

umol/l

0.4

0.2

—

(44806071)

101

1.28

0.30

1.0

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

1.29

0.30

1.3

1.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

370

1.13

0.30

1.5

3.9

3.1

0.19

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

230

1.17

0.29

1.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

399

1.12

0.29

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

399

1.12

0.29

1.2

1.1

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

1.22

0.28

1.1

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

952

9676

0.98

0.28

1.8

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

582

1.10

0.27

1.5

1.6

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

613

0.91

0.27

1.6

2.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

430

1.11

0.27

1.5

1.3

u/ml

3.6

1.4

0.61

196

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

224

0.84

0.26

1.8

161.5

202.3

1.31

218

(3001964) Herpes simplex virus Ag [Presence] in Specimen

205

1.17

0.26

2.1

1.6

—

(3007916) DNA double strand Ab [Titer] in Serum

0.69

0.26

1.0

1.3

—

230.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.68

0.26

1.4

1.2

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.27

0.25

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

628

6403

0.97

0.25

1.4

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

1.18

0.24

1.2

1.5

—

(4268621)

837

1.07

0.24

2.5

2.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

895

1.07

0.24

1.6

1.5

e6/l

4680.8

2445.3

0.76

630

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

161

1.17

0.23

1.2

1.4

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

255

1.13

0.22

3.3

3.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

1.28

0.22

1.2

1.6

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

417

1.10

0.22

4.7

6.4

mg/l

60.7

3581.2

2.14

298

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.74

0.22

1.0

3.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

284

1.12

0.22

2.0

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

716

1.07

0.21

1.8

2.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

345

0.89

0.21

3.6

2.6

9.9

11.4

0.45

326

(40759836) Histone Ab [Presence] in Serum by Immunoblot

399

1.10

0.21

1.2

1.1

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

0.00

0.21

0.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.3

—

(3046594) Interleukin 8 [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

32.6

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

1500.9

—

(3032868) Hemoglobin electrophoresis panel in Blood

101

0.79

0.21

1.4

1.5

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

187

0.85

0.21

1.0

1.1

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

698

1.07

0.21

3.2

2.8

e6/l

555.2

586.2

0.14

240

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.16

0.21

1.0

5.1

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.20

0.0

1.0

—

2.7

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.20

0.0

2.0

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

0.00

0.20

0.0

1.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

680

1.07

0.20

1.4

1.3

u/l

492.9

582.9

0.16

652

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.22

0.20

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

627

6118

1.02

0.19

1.5

1.4

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

797

1.06

0.19

1.7

2.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

332

0.90

0.19

3.7

2.5

30.4

29.7

0.11

314

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

164

1.15

0.19

1.3

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

885

1.06

0.19

1.5

62.3

62.0

0.02

579

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

278

1.11

0.19

2.0

2.9

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

278

1.11

0.19

2.0

2.9

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.21

0.19

1.1

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

153

0.85

0.18

1.2

1.4

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.18

1.2

1.0

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

288

1.11

0.18

1.1

u/l

24.9

40.7

1.00

225

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.18

0.18

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

289

1.10

0.17

1.1

u/l

76.0

107.5

2.09

237

(40765096) Chromosome analysis panel by Banding

215

0.88

0.17

1.3

1.2

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

1.12

0.17

3.0

1.5

nmol/l

46.1

17.8

—

(40758292) HTLV I+II Ab panel - Serum

183

0.87

0.17

1.4

1.3

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.11

0.17

1.0

1.1

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

156

1496

1.04

0.16

4.3

3.2

u/ml

772.0

4278.1

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

396

1.08

0.16

2.8

3.4

nmol/l

183.6

111.7

0.64

387

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

176

1.13

0.16

2.9

2.7

mg/l

120.0

47.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

120

1.16

0.15

1.1

1.0

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

417

1.07

0.15

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.19

0.15

1.0

1.1

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.82

0.14

1.1

1.0

—

(3034426) Prothrombin time (PT)

315

0.92

0.14

1.4

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

125

1199

1.04

0.14

1.4

1.3

u/ml

5.4

4.2

0.26

438

(3006462) Nitrate [Presence] in Urine

207

1.11

0.14

3.3

2.5

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

135

1299

1.03

0.13

3.5

3.9

u/ml

350.3

1317.1

1.06

129

1186

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

372

1.07

0.13

1.8

2.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

372

1.07

0.13

1.8

2.5

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

372

1.07

0.13

1.8

2.5

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

372

1.07

0.13

1.8

2.5

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

170

1.11

0.12

1.7

1.3

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

199

0.90

0.12

1.1

mg/g

9.1

9.8

0.12

190

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

228

1.09

0.12

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

881

0.96

0.12

2.5

2.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

219

0.91

0.12

1.3

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

588

1.05

0.11

8.4

7.9

u/ml

42.0

4776.3

0.68

169

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

588

1.05

0.11

3.4

2.9

e6/l

431.7

532.2

1.09

485

(3037556) Urate [Mass/volume] in Serum or Plasma

197

0.91

0.10

1.3

1.4

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

395

1.06

0.10

1.3

1.2

—

94.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

105

1.14

0.10

2.4

3.4

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

207

0.91

0.10

1.1

1.3

ug/l

34.2

142.3

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

182

1.09

0.10

1.1

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

572

1.04

0.10

2.0

1.8

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.14

0.09

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

202

1.08

0.09

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

280

1.07

0.09

2.0

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

232

1.07

0.09

1.2

1.9

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1.09

0.08

1.2

2.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

205

0.92

0.08

1.2

1.1

—

(3011048) Pyruvate [Moles/volume] in Blood

1.05

0.08

1.7

1.1

umol/l

88.3

85.6

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.13

0.08

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

116

1184

0.97

0.08

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

519

0.96

0.08

1.5

1.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

357

0.95

0.08

2.3

3.1

—

(21494434) Karyotype in Bone marrow

634

1.04

0.08

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

399

1.05

0.08

1.3

1.2

—

40.6

—

(4094501)

215

2104

1.02

0.08

1.1

—

(4212803)

1.02

0.07

1.1

1.0

—

(3014891) Appearance of Pleural fluid

1.13

0.07

1.1

1.6

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.84

0.07

1.1

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

784

1.03

0.07

1.2

titre

80.0

244.7

3.80

104

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

725

1.03

0.07

6.2

5.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

415

0.96

0.06

1.1

u/l

1.1

1.0

0.26

194

(40761995) Spermatozoa Progressive [#/volume] in Semen

726

1.03

0.06

3.1

2.9

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

102

0.88

0.06

1.1

1.5

—

(3045142) Bone marrow Pathology biopsy report

827

0.97

0.06

1.4

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

131

0.91

0.06

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

625

0.97

0.06

1.6

2.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

625

0.97

0.06

1.6

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

625

0.97

0.06

1.6

2.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

865

0.98

0.05

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

694

0.98

0.05

1.2

1.4

—

36.9

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

266

1.05

0.05

1.8

137.0

170.4

1.93

250

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

178

1.06

0.05

9.9

7.3

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

109

0.91

0.04

4.6

2.9

pmol/l

60.0

80.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

376

1.03

0.04

1.2

1.1

—

(3048879) Bone marrow aspiration report

189

1.05

0.04

1.2

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

258

1.04

0.04

9.9

7.6

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

279

0.96

0.03

1.5

1.4

66.0

60.0

0.41

235

(3024263) Appearance of Synovial fluid

389

0.97

0.03

1.4

1.8

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

527

1.02

0.02

2.3

1.8

—

(3047189) Immunofixation for 24 hour Urine

329

1.03

0.02

1.3

1.9

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

567

1.02

0.02

3.6

3.0

e9/l

0.2

0.58

483

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

187

0.96

0.02

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

340

1.02

0.02

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

116

0.94

0.01

1.3

1.2

—

348.0

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

808

1.01

0.01

1.1

mmol/l

8.0

7.5

0.40

591

(3038071) Oxygen [Partial pressure] in Mixed venous blood

232

1.03

0.01

10.0

7.6

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

828

1.01

0.01

1.7

1.5

e6/l

41504.8

54424.2

0.31

507

(3008898) HLA-B27 [Presence]

234

2320

1.00

0.01

1.1

—

(40768795) Lymph node Pathology biopsy report

610

1.01

0.01

1.3

—

(4211845)

233

1.03

0.00

3.2

2.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

145

0.96

0.00

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

258

1.00

0.00

3.7

2.6

e6/l

167.1

176.8

0.07

138

(3012441) Differential panel - Pleural fluid

806

1.00

0.00

1.7

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

120

1191

1.00

0.00

1.7

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

117

1166

1.00

0.00

1.1

113.7

113.2

0.06

112

1079

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

654

1.00

0.00

1.2

1.4

umol/l

14.0

12.8

0.65

615

(3010375) cycloSPORINE [Mass/volume] in Blood

421

0.99

0.00

25.3

24.9

ug/l

105.0

120.5

0.98

334

(3029396) Erythrocyte agglutination [Presence] in Blood

0.98

0.00

1.0

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.93

0.00

1.0

1.2

umol/24h

2.8

7.8

—

(3007463) Buprenorphine [Presence] in Urine

0.93

0.00

8.2

9.6

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.96

0.00

1.4

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

8.0

—

(40763629) HC gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.4

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.01

0.00

1.0

1.1

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

0.0

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

0.0

1.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

0.00

0.0

1.0

—

(36031836) Tocilizumab [Mass/volume] in Serum

0.00

0.0

1.0

—

14.2

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.89

0.00

1.0

1.2

—

(3022670) pH of Venous cord blood

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.2

—

257.0

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(36304079) Mucus [Presence] in Urine sediment

0.00

0.0

1.1

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.7

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.96

0.00

1.2

1.1

—

(3028468) Fragments [Presence] in Blood by Light microscopy

0.00

0.0

3.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.97

0.00

1.0

1.4

u/ml

25.3

90.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.92

0.00

1.6

1.3

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

0.00

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.02

0.00

1.0

2.8

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint N14_PHIMOSIS and mortality.

Females

No data

Males

Parameter	HR [95% CI]	p-value
N14_PHIMOSIS	1.419 [1.25, 1.61]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.025

During the follow-up period (1.1.1998 — 31.12.2019), 6047 out of 65740 males with N14_PHIMOSIS died.

Mortality risk

Mortality risk for people of age

years, who have N14_PHIMOSIS.

N-year risk	Females	Males
1	No data	0.341%
5	No data	1.94%
10	No data	4.629%
15	No data	8.563%
20	No data	14.111%

Relationships between endpoints

↥

Index endpoint: N14_PHIMOSIS – Redundant prepuce, phimosis and paraphimosis

GWS hits: 3

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Redundant prepuce, phimosis and paraphimosis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints